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CHAPTER I 
 
INTRODUCTION 
 
Overview of the dopamine system 
 Dopamine (DA) is a modulatory neurotransmitter that functions in the human 
body to regulate numerous aspects of behavior, mood, and motor function (Girault and 
Greengard, 2004).  From sleep cycles, appetite, and emotion- to sex, addiction, and 
psychopathy- the dopamine system contributes to components of humanity that are both 
necessary and evil (Lu and Zee, 2010, Blum et al., Buckholtz et al.).  In the mammalian 
brain, dopaminergic projections innervate brain regions adversely affected in psychiatric 
illnesses, including Parkinson’s disease, schizophrenia, attention deficit hyperactivity 
disorder, addiction, and mood disorders (Sillitoe and Vogel, 2008). However, the 
contribution of the DA system to the establishment of neuronal circuitry and the 
significance of DA signaling during development of the central nervous system remain 
unclear.  Understanding how dopaminergic pathways impact a developing brain may 
shed light on the organization of connectivity in diseases with a neurodevelopmental 
component.  Moreover, if DA is required for normal brain development, then early 
exposure to agents that interfere with the DA system could disrupt the trajectory of 
developmental events, precipitating behavioral abnormalities and even psychiatric 
illnesses. 
 
 
2 
Dopaminergic  projections 
 DA neurons originate mainly from two midbrain regions, the substantia nigra pars 
compacta (SNc) and the ventral tegmental area (VTA) (Figure 1.1) (Van den Heuvel and 
Pasterkamp, 2008). SNc neurons project via the medial forebrain bundle (MFB) to the 
dorsal caudate nuclei of the striatum (STR), forming the nigrostriatal pathway (Prasad 
and Pasterkamp, 2009).  The STR participates in extrapyramidal motor circuits involving 
the thalamus and motor cortex (Herrero et al., 2002).  VTA neurons send dopaminergic 
projections to the prefrontal cortex (PFC), forming the mesocortical pathway, and to the 
nucleus accumbens (NAcc), amygdala, and hippocampus to form the mesolimbic 
pathway (Van den Heuvel and Pasterkamp, 2008). The mesolimbic system mediates 
pleasure seeking, reward, and addictive behavior (Kauer and Malenka, 2007). The PFC 
controls executive function, decision-making, working memory tasks, and critical 
thinking skills (Arnsten and Li, 2005).  
 In the rat brain, the first MFB axons first reach the STR at embryonic day (E)14, 
then go on to enter the cortex (Van den Heuvel and Pasterkamp, 2008).  Tyrosine 
hydroxylase (TH)+ fibers immediately begin innervation of the STR and are diffuse by 
E18 (Van den Heuvel and Pasterkamp, 2008). Conversely, dopaminergic axons do not 
innervate the cortex right away.  TH+ fibers enter the subplate and intermediate zone but 
wait to enter the cortical plate (Verney et al., 1982).  A two day “waiting period” 
coincides with the progressive thickening of the cortex and expansion of white matter 
(Kriegstein et al., 2006). The innervation and establishment of functional DA synapses in 
the FC begins at E20 and is not complete until after birth (Van den Heuvel and 
Pasterkamp, 2008). 
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FIGURE 1.1: Ontogeny of dopaminergic innervation. A sagittal view of an embryonic 
rodent brain. DA axons extend from the midbrain to innervate striatal and cortical areas.  
The SN projects to the caudate putamen (blue lines), while the VTA projects to the 
ventral nucleus accumbens in the STR and the cortex (yellow lines).  Abbreviations: C, 
caudal; CTX, cortex; D, dorsal; MFB, medial forebrain bundle; SN, substantia nigra; 
STR, striatum; VTA, ventral tegmental area. 
 
Dopamine receptors 
 The five main dopamine receptors (DR)- DRD1, DRD2, DRD3, DRD4, and 
DRD5- are g-protein coupled receptors (GPCR) that are classically characterized by their 
ability to activate or inhibit production of cyclic AMP (cAMP)(Neve et al., 2004).  DRD1 
and DRD5 are considered “D1 like”, because both increase cAMP synthesis, and are 
structurally comparable, with each containing a single exon that is conserved in both 
human and rodent brains (Zhou et al., 1990, Girault and Greengard, 2004).  DRD2, 
DRD3, and DRD4 are “D2 like” and couple to Gαi, inhibiting adenylyl cyclase (AC) and 
thus decreasing cyclic nucleotide levels (Enjalbert and Bockaert, 1983, Girault and 
Greengard, 2004).  Members of the D2 family of receptors are encoded by multiple exons 
in both rodents and human, and various splice variants have been reported for these genes 
(Bunzow et al., 1988, Zhang et al., 2007).  For example, DRD2 exists in a common “long 
form” postsynaptically and a “short form” presynaptically (Lindgren et al., 2003).   The 
4 
presynaptic DRD2 receptors are autoreceptors that lack a portion of exons 5-6 and are 
expressed only in dopaminergic neurons (Goldstein et al., 1990).  While expression of 
DRs is mostly concentrated in regions receiving dense DA innervation, DRs are 
expressed in throughout the brain.  The highest levels of DRD1 and DRD2 are in the 
basal ganglia, and lower levels of DRs are found in the PFC, amygdala, nucleus 
accumbens, and hippocampus (Araki et al., 2007).  
 
Signaling mechanisms of dopamine receptors 
 As stated previously, the D1 class of dopamine receptors couples primarily to the 
stimulatory G-protein Gαs/olf, named for its ability to stimulate the production of cAMP 
(Neve et al., 2004). After binding GTP, Gαs/olf activates AC, a 12-transmembrane domain 
protein that converts ATP to cAMP (Figure 1.2) (Patel et al., 2001).  Gαs in the GTP-
bound form has a tenfold greater affinity for activating AC compared to the GDP-bound 
form (Sunahara et al., 1997).  The complex of AC and Gαs/olf functions as an active 
enzyme with AC comprising the catalytic unit and Gαs/olf the regulatory unit (Kandel, 
2000).  AC production of cAMP is terminated when Gαs/olf dissociates from the complex.  
cAMP is a diffusible molecule with two primary actions. First, cAMP can bind to 
cyclic nucleotide-gated ion channels (CNC) to modulate ion permeability. CNCs are non-
selective cation channels that promote Ca2+ entry into the cell (Kaupp and Seifert, 2002). 
Fluctuations in Ca2+ concentration can play a role in depolarization of the cell but are also 
very important for developmental and metabolic processes (Rutecki, 1992).  The second 
role of cAMP is to activate the cyclic AMP dependent kinase protein kinase A  
5 
 
FIGURE 1.2: Dopamine receptor signaling pathways. 
DA interacts with subtypes of DRs that activate GPCRs.  Activation of a DR results in conformational 
changes, allowing the Gβγ subunits dissociate from the Gα subunit. Depending on the properties of Gα, 
specific second messenger pathways are activated. D1 like receptors activate Gαs, which leads to 
accumulation of cAMP and activation of PKA and ERK1/2-mediated signaling cascades.  PKA 
phosphorylates membrane-bound ion channels that promote entry of calcium into the cell and 
membrane depolarization.  D2 like receptors inhibit this pathway by activating the Gαi protein.  The  
dissociated Gβγ subunit of the D2 receptor can activate signal transduction pathways in its own right, 
including the PLC pathway and GSK3B-mediated signaling.  PLC activation triggers release of 
calcium from stores in the endoplasmic reticulum.  Heterodimers of D1 and D2 receptors also activate 
the PLC pathway by activating the Gαq protein.  Adapted from (Bronson and Konradi, 2010). 
  
 (PKA) (Montminy, 1997). PKA transfers a phosphate from ATP onto the amino acids 
serine or threonine within particular amino acid consensus sequences in substrate proteins 
(Kandel, 2000). These consensus sequences confer increased substrate specificity 
(Ubersax and Ferrell, 2007).  
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 PKA can modulate neuronal excitability as well. Sodium and L-type Ca2+ 
channels have PKA phosphorylation sites that open the channels while potassium 
channels remain closed after PKA phosphorylation (Cantrell et al., 1997, Surmeier et al., 
2007).  The influx of cations will promote a state of depolarization in the cell and can 
facilitate activity of NMDA ionotropic receptors (Dudman et al., 2003).  NMDA 
receptors cannot be active unless the cell is initially depolarized to remove a Mg2+ ion 
that sits in the pore of the NMDA channel (Cavara et al., 2010). The activation of DRD1 
receptors and the cAMP pathway therefore functions to synergistically allow for NMDA 
receptor neurotransmission (Cepeda and Levine, 1998).  
 PKA has many substrates but a group of proteins called A Kinase Anchoring-
Proteins (AKAPs) enhance PKA specificity (Dell'Acqua et al., 2006).  These proteins 
target PKA to a specific substrate depending on the needs of the cell and a given stimulus 
(Wong and Scott, 2004). PKA affects such a diverse group of substrates and AKAPs aid 
in this process by anchoring PKA directly to a substrate (Wong and Scott, 2004).  The 
transcription factor cyclic AMP response element binding protein (CREB) is activated by 
PKA as well as kinases involved in the mitogen-activated protein kinase (MAPK) 
pathway (Montminy, 1997).  PKA also promotes amplification of its own kinase activity 
by phosphorylating inhibitor 1 (I-1 or DARPP-32) (Figure 1.2B) (Svenningsson et al., 
2004).  I-1 associates with protein phosphatase-1 (PP1) when I-1 is phosphorylated and 
prevents PP1 from removing phosphate molecules from PKA substrates, therefore 
amplifying PKA signals (Svenningsson et al., 2004).  When phosphorylated, DARPP-32 
no longer associates with I-1 but instead directly inhibits PKA activity (Svenningsson et 
al., 2004).  
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 D2-like receptors couple to a second G-protein, Gαi (Beaulieu and Gainetdinov, 
2011).  Gαi is an inhibitory G-protein, named for its ability to inhibit the AC and attenuate 
cAMP production (Brasser and Spear, 2004).  Gαi coupled receptors directly oppose 
Gαs/olf activation of cyclic AMP and promote hyperpolarization by inhibiting sodium and 
calcium ion flow while opening potassium channels (Surmeier et al., 2007).  DRD2 is 
also present on presynaptic cells, where it inhibits neurotransmitter release (Fisone et al., 
2007). DRD2 autoreceptors are expressed at midbrain dopaminergic synapses and are 
activated after dopamine is release from SN or VTA cells (Lindgren et al., 2003). 
Activation of the autoreceptor hyperpolarizes the presynaptic terminals to inhibit 
subsequent neurotransmitter release (Lindgren et al., 2003).  
 Recent studies have shown that D2-GPCRs exert some of their effects in vivo 
through cAMP-independent mechanisms (Beaulieu et al., 2007). The Gβγ effectors of 
DRD2 can act as receptor-regulated scaffolds and mediate a variety of receptor signaling 
and regulatory processes (Lefkowitz and Shenoy, 2005). This new mode of dopamine 
receptor signaling involves β-arrestin, protein kinase B (Akt) and protein phosphatase 2A 
(PP2A), proteins that have been classically implicated in GPCR desensitization (Beaulieu 
and Gainetdinov, 2011). The formation of this complex results in the 
dephosphorylation/inactivation of Akt by PP2A and the subsequent stimulation of GSK-
3β-mediated signaling (Beaulieu et al., 2005). GSK3β is a regulator of many cellular 
functions, including cell architecture, motility, and survival (Jope and Johnson, 2004).  In 
the Wnt signaling pathway, GSK3β forms a protein complex with PP2A, axin, and casein 
kinase that regulates the availability of free beta catenin, and in turn, transcription of 
Wnt-related genes (Jope and Johnson, 2004).    
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In addition, some neurons express both DRD1 and DRD2 receptors (George and 
O'Dowd, 2007).  The presence of multiple GPCRs in a given cell can regulate many 
aspects of neuronal signaling.  DRD1 and DRD2 can form hetero-oligomers which 
couple to Gαq/11 (Rashid et al., 2007).  Gαq/11 activates PLC, which converts 
phosphatidylinositol-4,5-bisphosphate into diacylglycerol (DAG) and IP3 (Figure 1.2C) 
(Selbie and Hill, 1998).  DAG is a glycerol derivative, which is found at low levels in 
biological membranes during resting potentials (Merida et al., 2008). Upon stimulation, 
the PLC isozymes cleave phosphatidylinositol-4,5-bisphosphate (PIP2) into DAG and 
IP3 (Suh et al., 2008).  Phospholipase D (PLD) can also metabolize phosphatidylcholine 
to form DAG (Brose et al., 2004). The most prominent target of DAG is the protein 
kinase C (PKC) family of Ser/Thr kinases (Yang and Kazanietz, 2003). Ultimately, 
integration of signaling properties from both types of G-proteins will play a role in 
determining how the cell signals in response to dopamine release.   
 
Dysregulation of DA in psychiatric disorders 
  
 Schizophrenia (SZ) is a devastating and debilitating mental disorder that affects 
approximately 1% of the world population (Picchioni and Murray, 2007).  Originally 
described by Kraepelin as “dementia praecox”, the term “schizophrenia”, meaning “split 
mind”, was coined by the Swiss physician Bleuler (Andreasen and Carpenter, 1993).  The 
disease is characterized by positive symptoms (hallucinations, psychosis, delusions), 
negative symptoms (withdrawal, avolition, anhedonia), and cognitive deficits that first 
appear during late adolescence or early adulthood (Picchioni and Murray, 2007).  It is 
widely accepted that a combination of prenatal insults, gene expression, and 
environmental factors lead to the manifestation of this illness (Lewis and Levitt, 2002, 
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Karlsgodt et al., 2008).  However, several pieces of evidence demonstrate DA system 
dysfunction in SZ, including: i) DRD2 antagonists ameliorate psychotic symptoms 
(Seeman, 2006); ii) function of the PFC, a region with DRs that receives DA innervation, 
is impaired (Seamans and Yang, 2004); iii) postmortem analysis of SZ brains reveals a 
decrease in (TH)+ and (DAT)+ axons innervating the PFC (Akil et al., 1999); and iv) 
administration of drugs that elevate the amount of synaptic DA, such as amphetamine and 
cocaine, induce psychosis in healthy individuals (Seeman et al., 2006).  
 An imbalance of DA innervation routes is believed to contribute to the 
symptomology of SZ whereby an overactive mesolimbic system elicits positive 
symptoms but an underactive mesocortical system leads to negative and cognitive 
symptoms by hindering cortical processing (Howes and Kapur, 2009).  From a 
neuroanatomical perspective, many lines of evidence suggest that schizophrenia is also a 
neurodevelopmental disorder of connectivity (McGlashan and Hoffman, 2000).  Genetic 
studies have shown association of the disease with the expression of polymorphisms of 
many developmental genes including those related to axon guidance, cell adhesion, and 
patterning of circuitry.  These include DISC1, ERBB4, Netrin-G1/G-2, NRG1, PLXN2A, 
ROBO1, SEMA3A, and SEMA3D (Eastwood et al., 2003, Li et al., 2006a, Mah et al., 
2006, Blackwood et al., 2007, Eastwood and Harrison, 2008, Fujii et al., 2011, Vehof et 
al., 2011).  Interestingly, patients with a microdeletion on chromosome 22q11, also called 
DiGeorge syndrome or velo-cardio-facial syndrome, have a 20-30 fold higher risk of 
developing schizophrenia than the general population (Gothelf et al., 2009).  The genes in 
the 22q11 region that are deleted encode transcription factors that pattern the formation 
of the cerebral cortex and genes that modulate DA metabolism, including COMT, FGF8, 
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PITX2, PRODH, and TBX1 (Prasad et al., 2008, Gothelf et al., 2009).  Early life insults, 
especially those involving the DA system, may profoundly contribute to the 
pathophysiology of schizophrenia and alter nervous system development in such a way 
that it cannot be corrected later in life.  Understanding how the DA system affects 
development of the cortex, as well as how DA circuits mature in patients with psychiatric 
disorders, is crucial to developing treatments for these conditions. 
 
Frontal cortex projections 
 Cortical neurons make synaptic contact with both local and distant targets.  
Neurons in cortical layers II and III project via the corpus callosum to contralateral 
cortical neurons.  Layer IV neurons project to the thalamus while layers V and VI project 
to other subcortical structures including the amygdala, hippocampus, and STR.  
Therefore, the miswiring of cortical circuitry has the potential to impair the function of 
multiple brain regions and may result in a wide range of behavioral deficits. 
 In addition to cognition, the PFC processes information from external stimuli that 
encode cues for drug-seeking behaviors, anxiety, and fear learning (Davidson, 2002).  
The PFC projects to the amygdala, a group of nuclei that mediate behaviors of fear, 
anxiety, and emotional processing (Davidson, 2002, Fuchs et al., 2007).  Deficits in 
associative learning and memory are observed in individuals with schizophrenia, who 
also display flattened affect, or lack of emotion (Benes, 2010).  Structurally, the PFC can 
be segregated into prelimbic and infralimbic regions that modulate different components 
of fear processing: prelimbic FC afferent connections to the amygdala are required for the 
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consolidation and expression of learned fear behaviors, whereas infralimbic FC-amygdala 
connections modulate extinction behaviors (Corcoran and Quirk, 2007).  
 Exposure to the psychostimulant drug cocaine increases dopaminergic tone and 
produces long lasting changes in the brain (Nestler, 2005).  Adolescent binge cocaine 
exposure in rats regulated gene expression in the PFC and resulted in altered attentional 
processing in adulthood (Black et al., 2006).  Cocaine administration can be used induce 
excess DA signaling in the developing brain.  DR activation from cocaine exposure may 
regulate other PFC-mediated behaviors, such as fear learning and anxiety, by regulating 
genes that establish PFC-amygdala circuits.   
 
Axon guidance 
 DR stimulation activates second messenger molecules that have been shown to 
modulate axon guidance, suggesting that DR-mediated signaling may contribute to the 
establishment of neuronal circuits (Xiang et al., 2002, Nishiyama et al., 2003, Bouchard 
et al., 2004, Rajadhyaksha and Kosofsky, 2005). During development of the cerebral 
cortex, neural progenitor cells proliferate in the ventricular zone (VZ), a region bordering 
the lateral ventricle of the forebrain (Caviness et al., 2008).  Neurons born in the VZ 
migrate along radial glia columns to the 6 layers of the cortex in an inside-out fashion, 
such that deep layer 6 forms first and more superficial layers form last (Caviness et al., 
2008).  Once they have reached their laminar position, neurons extend axonal processes 
and their growth cones begin the course of axon pathfinding (Caviness et al., 2008). 
Axon guidance factors influence the directional steering of axonal growth cones 
throughout the entire nervous system (Charron and Tessier-Lavigne, 2005).  Axonal 
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pathfinding allows neurons to locate their target synaptic location and is essential for 
establishment of neurotransmission. In the cerebral cortex, this time period coincides 
with the innervation of DRs from efferent dopaminergic axons (Van den Heuvel and 
Pasterkamp, 2008).   
 
Classification of axon guidance molecules 
 Molecules present in the neuronal environment guide axons to their targets where 
synapse formation will occur (Chen and Cheng, 2009).  The classical axon guidance 
molecules (AGMs) are categorized into four main groups: netrins, slits, ephrins, and 
semaphorins (see table 1.1) (Plachez and Richards, 2005).  Netrin, Sanskrit for “one who 
guides”, is a secreted molecule that interacts with its receptors, deleted in colorectal 
cancer (DCC), uncoordinated 5 (UNC5), and Down’s syndrome cell adhesion molecule 
(DSCAM) on the cell surface to mediate attraction or repulsion (Moore et al., 2007).  
Other forms of netrin, including netrin G1 and G2, have recently been characterized as 
membrane bound axon guidance molecules that interact with netrin-g ligands 
(Rajasekharan and Kennedy, 2009).  Slits are secreted molecules that only mediate 
repulsive events through the roundabout (ROBO) family of receptors (Bashaw and Klein, 
2010).  The semaphorins are a large group of axon guidance molecules with many 
different subgroups that mediate repulsion or attraction by interacting with neuropilin 
(NRP) and plexin receptors (Tamagnone and Comoglio, 2000).  Ephrins are membrane 
bound ligands that interact with eph receptors to signal contact-mediated repulsive events 
(Bashaw and Klein, 2010).  While many distinct patterns of expression exist for these 
axon guidance molecules throughout the nervous system, the combined expression of 
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guidance cues, receptors, and environmental signals in a given cell dictates the direction 
of outgrowth for an axon (Gallo and Letourneau, 1999, Yu and Bargmann, 2001).  
 
TABLE 1.1: Classification of axon guidance families. 
Family 
Secreted/Membrane 
bound Receptors Attractive or repulsive 
Ephrin Membrane-bound Ephs Repulsive 
Netrin Both DCC, UNC-5, DSCAM Both 
Slit Secreted Robos Repulsive 
Semaphorin Both Plexins and Neuropilins Both 
 
   
Mechanisms of axon guidance 
 Mechanisms for axon guidance differ depending on the signal transduction 
cascade of a given receptor but essentially all guidance events begin with the 
reorganization of the actin cytoskeleton in the growth cone region (Gallo and Letourneau, 
2004).  The activation of a receptor signals GTPase molecules to trigger biochemical 
cascades involved in a number of cellular processes related to axon outgrowth and 
cytoskeletal remodeling (Dickson, 2001).  In the GDP-bound form, GTPases are 
activated by guanine exchange factors  (GEFs) that exchange GDP for GTP (Hall and 
Lalli, 2010).  Conversely, GTPase activity is increased by GTPase-activating proteins 
(GAPs), that lead to attenuation of GTPase activity (Hall and Lalli, 2010).  Repulsive 
events are triggered by the activation of the GTPase Rho, which causes the formation of 
stress fibers, growth cone collapse, retraction of lamellipodia and filopodia, and 
depolymerization of actin (O'Donnell et al., 2009).  Repulsion requires the growth cone 
to change the direction of axon outgrowth, away from the source of the repulsive axon 
guidance molecule, and towards an environment that is permissible for reestablishment of 
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the growth cone (Plachez and Richards, 2005).  Attraction is mediated by the inhibition 
of Rho and the activation of the GTPases Cdc42 and Rac, which promote the formation 
of lamellipodia and filopodia on the growth cone, resulting in actin polymerization and 
extension of the growth cone towards the source of the guidance factor (O'Donnell et al., 
2009).  Rac is also required for some repulsive events but its activation is receptor-
specific (O'Donnell et al., 2009). Each family of AGMs has a unique signal transduction 
cascade involving the activation or inhibition of effector molecules that transduce signals 
from GTPases into cytoskeletal rearrangement, resulting in the directional steering of the 
axon (Hall and Lalli, 2010).   
 Axon guidance events are extremely sensitive to changes in the neuronal 
environment and can be modified rapidly.  Micropipette manipulations of axon guidance 
molecules can induce growth cone collapse within just 10 minutes and enhance attraction 
in 15 minutes (Lin and Holt, 2007).  These robust effects require asymmetrical 
organization of actin polymerization for directional steering, and the translation of new 
proteins within close proximity of the advancing growth cone (Leung et al., 2006, Lin 
and Holt, 2007).  A number of second messenger molecules involved in GPCR signaling 
cascades have been shown to modulate the response to a guidance cue.  Increases in 
cyclic nucleotides enhance attraction while decreases trigger repulsion (Piper et al., 
2007).  Likewise, activation of PKA, PI3K, and PLCγ cause attraction while their 
inhibition causes repulsion (Akiyama and Kamiguchi, Ming et al., 1999, Bouchard et al., 
2004).  These effects are most likely accomplished through the regulation of L-type 
calcium channels and intracellular calcium channels (Xiang et al., 2002, Nishiyama et al., 
2003).   Local calcium transients in the growth cone can greatly influence axon guidance 
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events, whereby too much or too little calcium will cause repulsion but an optimum 
amount mediates attraction (Gomez and Zheng, 2006).  
 
Netrin-1 mediated axon guidance  
 Netrin-1 (ntn-1) is a secreted cue that guides axons over short and long distances 
(Rajasekharan and Kennedy, 2009).  Under basal conditions, a small amount of the ntn-1 
receptor DCC is present on the plasma membrane surface and vesicular stores of DCC 
are maintained near the growth cone (Bouchard et al., 2004).  The interaction of ntn-1 
with a DCC receptor on the surface of a growth cone leads to the formation of DCC 
homodimers and the activation of a DCC-anchored signaling complex that contains focal 
adhesion kinase (Fak) and non-catalytic region of tyrosine kinase adaptor protein 
1(Nck1) (Figure 1.3A) (Shekarabi et al., 2005).  Ntn-1 binding induces Fak 
autophosphorylation and recruits the Src family kinases Src and Fyn to phosphorylate the 
cytoplasmic tail of DCC (Round and Stein, 2007).   These events lead to the activation of 
the GTPases Cdc42 and Rac1 and the inhibition of Rho (O'Donnell et al., 2009).  The 
effector molecule Pak1 links Cdc42 and Rac1 with the scaffold protein Nck1, while Trio 
and Dock1 function as GEFs for Rac1 (Lai Wing Sun et al., 2011). DCC signaling also 
regulates Arp2/3 activity and activates the actin-binding proteins neuronal Wiskott-
Aldrich syndrome protein (N-WASP) and Enabled/vasodilator-stimulated 
phosphoproteins  (ENA/VASP), which not only mediate actin assembly but also function 
as modulators of synapse formation as the growth cone advances to its target (Lai Wing 
Sun et al., 2011). The combined result of these effects is directed attraction of an 
advancing growth cone toward the ntn-1 gradient. 
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FIGURE 1.3: Ntn-1 signaling pathways.  
(A) Chemoattraction mediated by the DCC receptor. (B) Chemorepulsion mediated by 
DCC and UNC5 receptors.  Adapted from Lai Wing Sun et al. Development (2011). 
Abbreviation: 80s, eukaryotic ribosomes; Arp2/3, complex of the actin-related proteins 
ARP2 (ACTR2) and ARP3 (ACTR3); CDC42, cell division cycle 42; DAG, 
diacylglycerol; ERM-M, ezrin/radixin/moesin and merlin protein family; GEFs, guanine 
exchange factors; IP3, inositol 1,4,5-triphosphate; MAX1, motor axon guidance 
PH/MyTH4/FERM domain cytoplasmic protein; MLC, myosin light chain; mTOR, 
mammalian target of rapamycin; N-WASP, neuronal Wiskott-Aldrich syndrome protein; 
NCK1, non-catalytic region of tyrosine kinase adaptor protein 1; pAKT, phosphorylated 
RAC-alpha serine/threonine protein kinase; pCofilin, phosphorylated cofilin; pERK1/2, 
phosphorylated extracellular signal-regulated kinase 1/2; pFAK, phosphorylated focal 
adhesion kinase; pFYN, phosphorylated Src family kinase FYN; pLIMK, phosphorylated 
LIM domain kinase 1; pMEK1/2, phosphorylated mitogen-activated protein kinase kinase 
1/2; PAK1, p21-activating kinase 1; PI3K, phosphatidylinositol-3 kinase; PIP, 
phosphatidylinositol phosphate; PIP2, phosphatidylinositol (4,5) bisphosphate; PIP3, 
phosphatidylinositol (3,4,5) triphosphate; PKC, protein kinase C; PLCγ, phospholipase 
Cγ; RAC1, ras-related C3 botulinum toxin substrate 1; RHOA, Ras homologue gene 
family member A; ROCK, RhoA kinase; SHP2, Src homology region 2 domain- 
containing phosphatase 2; SRC, tyrosine kinase sarcoma.
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 Work in a Drosophila model indicates that the UNC5 receptor alone can mediate 
short-range repulsive events but DCC is required for long-range repulsion from ntn-1 
(Figure 1.3B) (Keleman and Dickson, 2001).  In mammals, repulsion from ntn-1 cues is 
mediated by heterodimers of DCC and UNC5 receptors (Hong et al., 1999).  Ntn-1 
binding leads to the phosphorylation of multiple residues on the intracellular part of 
UNC5 and the recruitment of the tyrosine phosphatase Shp2 (Tong et al., 2001, Li et al., 
2006b).  While these effects are mediated by Src and Fak (Li et al., 2006b), little is 
known about the effector molecules that function downstream of UNC5 activation or how 
the DCC receptor participates in repulsive signaling cascades.  Shp2 can regulate activity 
of a number of effectors and second messengers known to induce cytoskeletal 
remodeling, including PLCγ, PI3K, and RhoA, but additional studies are needed to link 
UNC5 involvement to these pathways (Tong et al., 2001, Round and Stein, 2007).  
 As mentioned above, ntn-1-mediated axon guidance properties are sensitive to 
neuronal changes induced by second messenger cascades, many of which are regulated 
by DR signaling.  For example, the two classes of DRs modulate neurotransmission and 
cell excitability by regulating the activity of ion channels and intracellular calcium levels 
(Surmeier et al., 2007).  Neuronal depolarization and PKA activation can rapidly enhance 
netrin-mediated insertion of DCC into the plasma membrane (Bouchard et al., 2004, 
Bouchard et al., 2008, Nishiyama et al., 2008). PKA activation alone does not have the 
ability to mediate axon outgrowth or switch a cue from repulsion to attraction, but it can 
modify a growth cone’s sensitivity to ntn-1 gradients (Moore and Kennedy, 2006).  The 
ratio of the cyclic nucleotides cAMP and cGMP, as well as intracellular calcium levels, 
can determine if a cell is attracted or repelled from ntn-1 (Ming et al., 1997, Hong et al., 
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2000, Nishiyama et al., 2003).  Calcium-mediated activation of calcium/calmodulin 
dependent protein kinase II (CamKII) and calcineurin phosphatase I (PPI), which have 
been studied extensively for their role in dopaminergic and glutamatergic 
neurotransmission, induce attraction or repulsion, respectively, to ntn-1 cues (Wen et al., 
2004).  
 Currently, it is not known if DR stimulation alone can modify ntn-1 mediated 
axon guidance.  The aforementioned studies suggest that activation of a GPCR cascade 
involving Gαs will promote attraction to ntn-1 through the regulation of PKA, cAMP, and 
L-type calcium channels.  Conversely, activation of Gαi may trigger repulsion from ntn-1 
by inhibiting activity of these signaling molecules.  This theory is supported by data that 
indicate that the Unc5 homolog Unc5H2 can associate with the Gαi protein in the 
presence of cAMP (Komatsuzaki et al., 2002).  Under conditions of ntn-1 mediated 
attraction, Unc5 might bind Gαi to ensure attraction and not repulsion (Komatsuzaki et al., 
2002).  Decreases in cAMP would release Unc5 from Gαi, allowing Gαi to inhibit 
adenylyl cyclase production and decrease cyclic nucleotide levels (Komatsuzaki et al., 
2002).   
 Dopamine has the ability to activate both Gαs and Gαi, as well as a third g-protein, 
Gαq, which could also regulate axon guidance through activation of the second messenger 
molecules PLC, IP3, and PI3K (Ming et al., 1999, Xiang et al., 2002).  Additionally, 
another monoamine, serotonin (5-HT), has been shown to function as a modulator of ntn-
1-mediated guidance in the mouse brain (Bonnin et al., 2007).   5-HT receptors, like DRs, 
are GPCRs and stimulation of 5-HT1B and 5-HT1D receptors, which both couple to GαI, 
converts attractive ntn-1 cues to repulsive cues (Bonnin et al., 2007).  In vivo data with in 
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utero electroporation of 5-HT1B/1D siRNA in E14 mouse thalamocortical axons revealed 
drastic changes in the trajectory of these axons, suggesting that monoamine receptor 
stimulation is required for ntn-1-mediated guidance events (Bonnin et al., 2007).  The 
interaction of g-proteins with netrin receptors represents a novel field of study that may 
explain the relationship between neurotransmitter systems and developmental cues in 
establishing neuronal circuitry.  
 
Regulation of axon guidance molecules by DA signaling  
 Given the role that AGMs play in the establishment of neuronal circuitry, it is 
imperative that their signaling mechanisms are tightly regulated.  Recent studies have 
shown that AGMs are regulated by DR agonists and psychostimulants that increase 
dopaminergic tone (Halladay et al., 2000, Bahi and Dreyer, 2005, Jassen et al., 2006, 
Yetnikoff et al., 2007).  In a neuroepithelial cell line, the DRD1 agonist SKF81927 and 
the partial DRD1/DRD2 agonist dihydrexidine regulated expression of receptors for ntn-
1, ephrin, and semaphorin (Jassen et al., 2006).  Pre- and peri-natal cocaine exposure 
increased expression of EphB1 the cortex and STR (Halladay et al., 2000). 
 Interestingly, drugs of abuse regulate axon guidance molecules and their receptors 
in adolescent and adult and animals, well after initial axon guidance events have taken 
place. Amphetamine administration in adolescent rats increased protein expression of 
both ntn-1 receptors in the PFC (Yetnikoff et al., 2007).  An extensive study in adult rats 
showed regulation of semaphorin and ephrin family molecules in multiple brain regions 
after acute and chronic cocaine exposure, as well as in response to cocaine sensitization 
and withdrawal (Bahi and Dreyer, 2005).  Large, treatment-specific patterns of regulation 
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were observed, with some genes regulated by a cocaine challenge after withdrawal, and 
others regulated throughout all treatment paradigms (Bahi and Dreyer, 2005).  These data 
suggest that the regulation of axon guidance molecules in response to cocaine may be 
associated with other processes that contribute to the addiction process- such as the onset 
of addiction and cravings, drug reinstatement cues, or withdrawal.   
 Expression of AGMs in adult animals suggests that AGMs have another role after 
axon guidance processes cease, such as the maintenance of synapses and dendritic 
architecture.  This could be a mechanism of plasticity following the drug treatment, 
emphasizing the importance to study the effects of DR stimulation in development as 
well as postnatal periods.  The interaction of DA signaling properties with axon guidance 
systems may represent not only a relationship that is crucial for circuit formation, but also 
one that contributes to the behavioral and cognitive impairment in psychiatric illnesses.    
 
 
Rationale  
 The DA system modulates frontal cortex (FC) activities such as working memory 
and attentional processing.  Dysfunction of the FC has been observed in psychiatric 
illnesses with a neurodevelopmental basis and thus processes that govern the formation of 
FC circuitry need to be thoroughly understood. In the developing rodent brain, DRs are 
expressed in the FC during periods of axonal pathfinding.  Ntn-1 is a secreted axon 
guidance cue that guides cortical neurons that express its receptors, DCC and UNC5C.  
DCC homodimers mediate attraction, while DCC-UNC5C heterodimers cause repulsion.  
DR stimulation activates G-proteins that regulate molecules known to influence ntn-1 
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mediated axon guidance, including cyclic nucleotides, protein kinase A (PKA), 
phospholipase C (PLC), and calcium.  Abnormalities in DR activity during ntn-1 
mediated axon guidance may alter FC neuronal circuitry and lead to dysfunction of the 
FC later in life. 
 
Hypothesis 
We hypothesized that DR stimulation during early cortical development regulates the 
response of cortical neurons to the ntn-1 cue and can alter PFC-mediated behaviors later 
in life.   
 
Specific Aims of Thesis 
I. Determine expression levels of the ntn-1 system and DRs in the developing rodent FC.   
II. Determine how DR stimulation affects the expression levels of ntn-1 receptors. 
III. Determine how DR stimulation affects FC axon guidance in the presence of ntn-1. 
IV. Determine the effect of adolescent cocaine administration on PFC-associated    
      behaviors of fear and anxiety. 
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CHAPTER II 
 
EXPRESSION AND FUNCTION OF DOPAMINE RECEPTORS IN THE 
DEVELOPING MEDIAL FRONTAL CORTEX AND STRIATUM OF THE RAT 
 
 
Abstract: 
The timeline of dopamine (DA) system maturation and the signaling properties of 
dopamine receptors (DRs) during rat brain development are not fully characterized.  We 
used in situ hybridization and quantitative PCR to map DR mRNA transcripts in the 
medial frontal cortex (mFC) and striatum (STR) of the rat from E15 to E21.  The 
developmental trajectory of DR mRNAs revealed distinct patterns of DA receptors 1 and 
2 (DRD1, DRD2) in these brain regions.  Whereas the mFC had a steeper increase in 
DRD1 mRNA, the STR had a steeper increase in DRD2 mRNA.  Both DR mRNAs were 
expressed at a higher level in the STR compared to the mFC.  To identify the functional 
properties of DRs during embryonic development, the phosphorylation states of CREB, 
ERK1/2, and GSK3β were examined after DR stimulation in primary neuronal cultures 
obtained from E15 and E18 embryos and cultured for three days to ensure a stable 
baseline level.  DR-mediated signaling cascades were functional in E15 cultures in both 
brain regions.  Because DA fibers do not reach the mFC by E15, and DA was not present 
in cultures, these data indicate that DRs can become functional in the absence of DA 
innervation.  Since activation of DR signal transduction pathways can affect network 
organization of the developing brain, maternal exposure to drugs that affect DR activity 
may be liable to interfere with fetal brain development. 
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Introduction 
The monoamine dopamine (DA) modulates neurotransmission and neuronal 
excitability via activation of second messenger cascades coupled to DA receptors (DRs).  
DRs are g-protein coupled receptors (GPCRs), characterized by the g-protein that they 
couple to: DRD1 “like” couple to Gαs and DRD2 “like” couple to GαI (Girault and 
Greengard, 2004, Neve et al., 2004, Seamans and Yang, 2004, Bronson and Konradi, 
2010).  Abnormal function of the DA system has been associated with neuro-psychiatric 
disorders such as Parkinson’s disease, attention deficit hyperactivity disorder (ADHD), 
and schizophrenia (Barzilai and Melamed, 2003, Goto and Grace, 2007, Genro et al., 
2010).  The DA system is furthermore involved in reward pathways and addiction to 
drugs such as cocaine and amphetamine (Kauer and Malenka, 2007).   
While DA pathways have been studied in great detail in the adult brain, the role 
and functional state of the DA system during development is not well established in rats.  
In the rodent brain, DRs have been detected in mid to late embryonic development in the 
medial frontal cortex (mFC), a heavily interconnected brain area involved in attention, 
cognition, and working memory (Schambra et al., 1994).  At around the same time, DA 
receptors appear in the striatum (STR), a brain area implicated in motor behavior, 
motivation, and reward (Sales et al., 1989, Jung and Bennett, 1996, Arnsten and Li, 2005, 
Araki et al., 2007, Van den Heuvel and Pasterkamp, 2008).  During early brain 
development, events such as cell proliferation, differentiation, neuronal migration, and 
axon guidance are creating neuronal patterns and connections that determine brain 
function throughout life.  Neuronal progenitor cells from the ventricular zone proliferate 
and begin to populate cortical layers V and VI around embryonic day (E) E15 in the rat 
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brain (Kriegstein et al., 2006).  Simultaneously, interneurons from the ganglionic 
eminences migrate tangentially into the cortex (Marin and Rubenstein, 2001).  Midbrain 
ventral tegmental area (VTA) and substantia nigra (SN) neurons project via the medial 
forebrain bundle (MFB), arriving in the ventral and lateral regions of the rat STR at E14, 
and in the remaining areas of the STR by E18.  MFB projections from the VTA continue 
past the STR and reach the subplate and intermediate zone of the mFC at E18 (Verney et 
al., 1982, Berger et al., 1983, Kalsbeek et al., 1988).  DA positive fibers remain in this 
region for two days before entering the cortical plate at E20 (Van den Heuvel and 
Pasterkamp, 2008). 
Because the rodent brain undergoes rapid changes during embryogenesis, a 
detailed characterization of the spatial and temporal expression patterns of DRD1 and 
DRD2 in the prenatal rat brain is essential.  It is currently not known at what age DRs 
become functional and whether their signaling cascades in the embryonic brain reflect the 
known properties of DRs in adult animals.   
In adult neurons, DRD1 activates adenylate cyclase, increases levels of cyclic 
nucleotides, activates protein kinase A (PKA) and mediates the phosphorylation of 
substrate molecules such as cyclic AMP response element binding protein (CREB) 
(Dudman et al., 2003), and extracellular signal-related kinase 1/2 (ERK1/2) (Valjent et 
al., 2000).  DRD2 stimulation inhibits adenylate cyclase (Enjalbert and Bockaert, 1983) 
and activates beta arrestins and protein phosphatase 2A (PP2A) which inhibit protein 
kinase B (Akt), leading to the dephosphorylation and activation of glycogen synthase 
kinase 3 beta (GSK3β), a kinase involved in Wnt signaling (Cross et al., 1995, Beaulieu 
et al., 2009).   
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DRs activated in the embryonic brain modify neuronal migration, cell cycle 
activity, and cell morphology (Sales et al., 1989, De Vries et al., 1992, Todd, 1992, 
Schmidt et al., 1996, Stanwood et al., 2001, Song et al., 2002, Zhang and Lidow, 2002, 
Ohtani et al., 2003, Popolo et al., 2004, Zhang et al., 2005, Crandall et al., 2007).  Recent 
studies indicate that monoamines and their signaling pathways can modulate axon 
guidance events in the embryonic brain by altering levels of cyclic nucleotides in the 
growth cone (Ming et al., 1997, Ming et al., 1999, Halladay et al., 2000, Nishiyama et al., 
2003, Bouchard et al., 2004, Bonnin et al., 2007).  Moreover, stimulation of the DA 
system in the adult brain, via external factors such as drugs of abuse, has also been shown 
to regulate axon guidance molecules in various brain regions (Bahi and Dreyer, 2005, 
Jassen et al., 2006, Yetnikoff et al., 2007, Sillivan et al., 2011).   
Knowledge of the expression and functional state of DRD1 and DRD2 during 
early embryonic development is vital for our understanding of how the DA system 
contributes to cortical and subcortical organization and thus might be involved in the 
developmental aspects of neuro-psychiatric disorders such as schizophrenia.  In the 
present study, we address this question in the mFC and STR of the developing rat brain. 
 
Material and Methods: 
Animals 
 All animals were housed and maintained in accordance with the policies of 
Vanderbilt University, which is accredited by the Association for the Assessment of 
Accreditation of Laboratory Animal Care.  Timed-pregnant female Sprague-Dawley rats 
(Charles River, Wilmington, MA) were anesthetized with pentobarbital (65mg/kg, 
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Sigma, St. Louis, MO) and embryos were removed and washed in sterile phosphate 
buffered saline (PBS). 
 
Primary neuronal cultures 
 mFC or STR tissue from E15 and E18 embryos were dissected under a stereo 
microscope (see figure 2.1), dissociated in media, and plated onto 6 well plates at a 
density of approximately 500,000 cells per well, as previously described (Rajadhyaksha 
et al., 1999).  For stimulation of DRs, cells were grown for 72 hours in vitro and treated 
for 15 minutes with 50µM of the DR agonists (+)-SKF 82958 hydrobromide, or (±)-
PPHT hydrochloride (N-0434) (Sigma).  Experiments were carried out at least in 
duplicates and in at least two independent dissections. 
 
Generation of nested RNA Probes 
RNA extraction and cDNA synthesis were performed as previously described 
(Sillivan and Konradi, 2011).  PCR products were used for vitro transcription with 
modifications of a published protocol (Kuppenbender et al., 2000).   Two sets of nested 
primers were designed for each target sequence within DRD1 and DRD2 with the help of 
Primerblast (http://www.ncbi.nlm.nih.gov/tools/primer-blast), whereby the internal 
primer pair included sequences that encoded either Sp6 or T7 RNA polymerase 
recognition sites (table 2.1A).  One µg of the nested PCR product was used to synthesize 
digoxigenin-labeled RNA probes using Sp6 (sense) or T7 (antisense) polymerase with the 
Dig RNA Labeling Kit (Roche Applied Science, Porterville, CA).   
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Northern blot method  
 Three µg of whole rat brain RNA was loaded per well of a denaturing 
formaldehyde gel (1X 4-Morpholinepropanesulfonic acid (MOPS) with 10% 
formaldehyde).  Following size-separation, RNA was electrophoretically transferred to a 
charged nylon membrane in 1X tris-acetate-ethylenediaminetetraacetic acid (EDTA) 
(TAE) buffer.  The membrane was UV-crosslinked and dried overnight before 
hybridization.  Prehybridization was carried out in NorthernMax Hybridization Buffer 
(Ambion, Austin, TX) followed by hybridization of probe at 0.25 ng/µl.  The membrane 
was washed twice at room temperature in 2X saline-sodium-citrate (SSC) buffer and 
twice at 65°C in 0.2XSSC for 30 minutes.  The membrane was incubated in blocking 
solution (100mM Tris-HCl, 150mM NaCl with 3% blocking reagent; Roche) followed by 
alkaline phosphatase-conjugated anti-digoxigenin antibody at a 1: 50,000 dilution 
(Roche).  After washing in 0.1M maleic acid buffer (pH 7.5), the membrane was 
equilibrated with diluted (1:250) alkaline-phosphatase luminescent substrate 2-chloro-5-
(4-methoxyspiro(1,2-dioxetane-3,2'-(5'-chloro)tricyclo[3.3.1.13,7]decan)-4-yl)-
phenylphosphate (CDP-Star) (Roche) and imaged using a Kodak I440 CS Imaging 
system (Kodak, Rochester, NY). 
 
In situ hybridization 
 Embryonic brains were fixed overnight in 4% paraformaldehyde (PFA), freeze-
protected in a series of graded sucrose solutions (10-30%), and cut to a thickness of 20 
µm on a cryostat.  Hybridization was carried out as described (Bonnin et al., 2007) with 
modifications.  A cocktail of three digoxigenin-labeled probes, covering three separate 
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mRNA stretches for each gene of interest was hybridized at a concentration of 0.25-ng/µl 
per probe to the sections for 18 hours at 60°C.  Adjacent sections were incubated in 
parallel with antisense and sense probes to control for nonspecific binding, and each slide 
contained brain slices from an entire developmental set (E15, E17, E19, E21).  Following 
hybridization, sections were blocked with 3% blocking reagent (Roche) and incubated 
overnight in alkaline phosphatase-conjugated anti-digoxigenin antibody at 1:2,000 
dilution (Roche).  The phosphatase reaction was carried out in a solution containing 
0.2mM 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and 0.2mM nitroblue tetrazolium 
(NBT).  Sections were dehydrated and mounted with Permount (Fisher).  Images were 
captured using Stereo Investigator software (MBF BioScience, Williston, VT).  
Densitometric analyses were done with Kodak Imaging software using 2 animals per time 
point.  Measurements were taken from the cortical plate of the mFC and the STR (see 
figures 2.2, 2.3).  To control for nonspecific hybridization and endogenous phosphatase 
activity, the intensity of the antisense signal was normalized to the sense signal from each 
adjacent section.   
 
QPCR  
 For mRNA analysis of DRs in tissue, samples were collected from E15, E17, E19, 
and E21 embryos and frozen at -80°C until RNA extraction.  RNA extraction, cDNA 
synthesis, and QPCR were performed as previously described (Sillivan and Konradi, 
2011).  Prior to cDNA synthesis, RNA was treated with DNase I, amplification grade 
(Invitrogen), for 15 minutes at room temperature to prevent DNA contamination.  DNase 
activity was stopped with 25mM EDTA and incubation at 65°C.  Primer sequences are 
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listed in table 2.1B.  All samples were examined in duplicate and values were normalized 
to the internal controls ß-actin and 18S ribosomal RNA (18S rRNA), two genes that are 
among the more evenly expressed during development (McCurley and Callard, 2008).  
To ensure that the normalization control genes were not introducing false results, all data 
were analyzed without normalization, with each individual normalization control gene 
and with both normalization control genes combined.  Although ß-actin had a tendency to 
be regulated in the same direction as the dopamine receptor mRNAs, comparable 
statistical differences were seen in each analysis.  Each QPCR plate had a standard curve 
of which efficiency and coefficient of determination values were examined to verify the 
quality of the experiment.  Expression levels were calculated using the formula (1/2^Ct) 
and all data were collected at the same fluorescence threshold.  Five samples were 
analyzed for each time point with each sample generated from multiple animals.  Each 
individual QPCR sample was composed of tissue from 4 animals for E15, 3 animals for 
E17, and 2 animals for E19 and E21. 
 
Western Blotting  
 Primary neuronal cultures were harvested in 1X Laemmli buffer and sonicated.  
Samples were heated to 80°C for 10 minutes and separated on 10-20% Tris-Glycine 
gradient gels (Invitrogen).  Proteins were transferred to polyvinylidene fluoride (PVDF) 
membranes (Perkin Elmer, Waltham, MA) and membranes blocked with animal-free 
blocking solution (Vector Laboratories, Burlingame, CA).  Primary antibodies were 
diluted in blocking solution and incubated with membranes overnight at 4°C.  The 
following antibodies were used: anti-phospho CREB (Serine 133) 1:4000, anti-phospho  
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TABLE 2.1: List of primer sequences used for synthesis of in situ probes (A), and 
QPCR (B). 
 
 
 
 
 
ERK1/2 (P44/42 MAPK-Threonine 202/Tyrosine 204) 1:2000, and anti-phospho GSK3β 
 (Serine 9) 1:2000 (Cell Signaling, Danvers, MA).  Membranes were washed 6 times in 
50mM tris-buffered-saline with 0.05% tween-20 (TBS-T) and incubated for 30 min at 
room temperature with horseradish peroxidase (HRP)-conjugated secondary antibodies 
(Vector Laboratories) prepared in blocking solution.  Blots were immersed in 
chemiluminescent reagents (Pierce, Rockford, IL) and exposed using a Kodak Imaging 
Station.  MemCode Reversible Protein Stain (Thermo Scientific, Rockford, IL) was used 
prior to immunodetection to measure total protein per well.  Proteins of interest were 
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normalized to total protein (Aldridge et al., 2008) or beta actin (1:20,000; Sigma), 
detailed in the figure legends.     
 
Statistics 
 Analyses of variance (ANOVAs) were applied to developmental timecourses of 
each receptor, and multivariate ANOVAs were applied to compare differences in the 
developmental trajectories between DRD1 and DRD2 mRNA expression levels (repeated 
measures), as well as between mFC and STR.  Post-hoc tests included paired t-tests to 
compare the expression of DRD1 to DRD2 within each sample at each time point and 
unpaired t-test for comparisons between the mFC and STR.  For western blots and in situ 
hybridization, unpaired t-tests were used for 2-group comparisons and ANOVAs in cases 
of 3 or more groups.  The JMP computer program (Cary, NC) was used for all analyses.  
Multiple comparison corrections were carried out for Western blots using the correction 
method developed by Benjamini and Hochberg (Benjamini and Hochberg, 1995), 
correcting for the three different phosphorylation antibodies within each time point and 
brain area.  However, since Western data are only semi-quantitative and were obtained 
from independent dissections with independent control samples, multiple-comparison 
corrections might not be appropriate and may introduce false-negative findings.  This is 
supported by the observation that some of the significant data that did not survive 
multiple-comparison corrections should be significant according to the literature (see 
‘Results’ for details).  We therefore present simple t-tests and note whenever data did not 
survive multiple comparison corrections. 
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Results 
Detection of DR mRNA transcripts in the developing rat brain 
 The individual probes for DRD1 and DRD2 detected a single band of 
mRNA transcript of the expected size (figure 2.1A).  mRNA expression of DRD1 and 
DRD2 was assessed spatially and temporally by in situ hybridization in coronal brain 
slices of embryonic rats from E15 to E21, at two different levels for mFC and STR 
(figure 2.1B).   
In both brain areas, little expression of DR mRNAs was detected at early time 
points but expression increased for both receptors over time (figure 2.2, 2.3).  In a 
preliminary analysis, we used t-tests to compare the expression levels of DRD1 and 
DRD2 mRNA at each developmental time point after subtracting the sense intensity 
measure from the antisense intensity to correct for background levels (figure 2.4A, 2.4B).  
Whereas no significant differences were seen at early time points, levels of DRs were 
significantly different at E19 in the mFC and at E21 in the STR.  This analysis suggested 
that the trajectories of DRs were divergent, with more DRD1 mRNA in the mFC, 
compared to DRD2, but more DRD2 than DRD1 in the STR. 
 
Quantification of DR mRNA transcripts by QPCR analysis 
 The in situ method provided an anatomical overview over the brain areas of 
interest, but it was only semi-quantitative and for repeated measures relied on 
densitometry estimates across different slides with some variation in background 
intensities.  For quantification purposes we employed QPCR analysis in samples from an 
independent cohort of embryonic rats, a method well suited for a comprehensive   
32 
 
FIGURE 2.1: Generation of DR probes to measure mRNA transcripts in rat brain. 
Three non-overlapping RNA probes were generated for both DRD1 and DRD2 and combined for in 
situ hybridization studies.  Each probe (labeled ‘1’, ‘2’, ‘3’) was examined individually in Northern 
blots using RNA from whole rat brain (A).  Arrows indicate the 28S and 18S rRNA bands.  Expected 
size of DRD1 mRNA is approximately 4 kB and DRD2 is approximately 2.7kB (Beaulieu et al., 2007, 
Iwakura et al., 2008).  The approximate size of the 28S band in rats is 4.8 kB and 18S is 1.9 kB.  (B) 
Schematic of an embryonic rodent brain.  For in situ analyses, probes were hybridized to coronal 
sections taken from the mFC (1) or STR (2).  D=dorsal, C=caudal.  (C-E) Dissection strategy for 
primary neuronal cultures, QPCR and Western blots.  (C) Dorsal view with the first three cuts (1-3) 
that removed septum and midbrain.  (D) Hemispheres were rotated to a sagittal view from the lateral 
ventricle onto the inside of the cortex.  The part of the hippocampus that was not removed by cuts 2 or 
3 was lifted up and FC was cut out as shown (cuts 4 and 5).  (E) Coronal view to show how striatum 
was removed from RH and NC (cut 6).  (F) Coronal brain slices from E15 to E21.  The lighter colored 
regions indicate the approximate area of mFC and STR dissected.  mFC was dissected rostral to this 
area, and STR caudal to this area.  Abbreviations: FC: frontal cortex; HP, hippocampus; LV, lateral 
ventricle; NC, neocortex; OB, olfactory bulb; RH, rhinencephalon; SP, septum; ST, striatum.  Scale 
bar 500µM. 
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FIGURE 2.2: In situ hybridization of DRD1 development in rat mFC and STR. 
Representative photomicrographs of in situ hybridization of coronal sections of embryonic rat brains 
at E15, E17, E19, and 21.  A combination of three DRD1 probes was used to visualize the expression 
of receptors in mFC (left panel) and STR (right panel).  For each time point, a representative antisense 
slide is shown next to a sense slide to show background levels of hybridization.  Boxes indicate the 
regions used to measure in situ densitometry.  Scale bar is 500µM.   
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FIGURE 2.3: In situ hybridization of DRD2 development in rat mFC and STR. 
Representative photomicrographs of in situ hybridization of DRD2 receptors in coronal sections of 
embryonic rat brains from E15 to E21.  A combination of three DRD2 probes was used to detect 
receptors in mFC (left panel) and STR (right panel).  For each time point, a representative antisense 
slide is shown next to a sense slide to show background levels of hybridization.  Boxes indicate the 
regions used to measure in situ densitometry.  Scale bar is 500µM. 
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statistical analysis.  Similar patterns to the in situ hybridization were found, with the 
exception that measurable amounts of mRNA could be detected at E15 (figure 2.4C, 
2.4D).  From E15 to E21 both receptors were significantly increasing in the mFC (DRD1: 
F3,16=47.0, p<=0.0001; DRD2: F3,16=191.7, p<=0.0001, (figure 2.4C).  Levels ofDRD1 
increased more than levels of DRD2, and this difference was supported in a multivariate 
ANOVA which showed significant differences between DRD1 and DRD2 (F3,16=8.1, 
p<=0.0017; repeated measure [DRD1, DRD2] x embryonic day).  In concordance, the 
ratio of DRD1/DRD2 in the mFC was different at different developmental stages (F3,16= 
24.5, p<=0.0001), (table 2.2A).  Except for E15, DRD1 levels were significantly higher 
than DRD2 levels in the mFC at all time points (table 2.2A), supporting the preliminary 
findings in the in situ hybridization analysis. 
In the STR, both receptors showed a steady increase from E15 to E21 as well 
(DRD1: F3,16=15.0, p<=0.0001; DRD2: F3,16=19.8, p<=0.0001), with significant 
differences between DRD1 and DRD2 (F3,16=17.1, p<=0.0001; repeated measure 
[DRD1, DRD2] x embryonic day).  The ratio of DRD1/DRD2 in the STR was different at 
different developmental stages (F3,16= 10.2, p<=0.0005), (table 2.2B).  Levels of DRD2 
were significantly higher than levels of DRD1 at all time points (figure 2.4D).  The 
overall expression of both receptor mRNAs was higher in the STR than the mFC 
(F3,16=10.7, p<=0.0004 for DRD1; F3,16=16.3, p<=0.0001 for DRD2; repeated measure 
[mFC, STR] x embryonic day), (table 2.3; figures 2.2, 2.3, and 2.4). 
To examine functional maturation of the receptors, the signaling properties of 
each receptor were evaluated with specific DR agonists in primary neuronal cultures.   
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TABLE 2.2: Ratio of DRD1 over DRD2 mRNA expression in the developing rat 
brain.   
The ratio of the two receptors +/- S.E.M.  is shown at each developmental time point in 
the mFC (A) and the STR (B).  QPCR values for each receptor were normalized to the 
control genes beta actin and 18S rRNA, and averaged from five samples per 
developmental time point.  Paired t-tests were used to analyze the difference between 
DRD1 and DRD2 levels. 
 
A. mFC Developmental timepoint DRD1/DRD2 t-test 
 E15 0.90 ± 0.04 0.0470 
 E17 1.97 ± 0.15 0.0046 
 E19 2.35 ± 0.16 0.0002 
 E21 1.37 ± 0.12 0.0398 
B. STR    
 E15 0.45 ± 0.07 0.0325 
 E17 0.82 ± 0.05 0.0488 
 E19 0.82 ± 0.05 0.0149 
 E21 0.67 ± 0.05 0.0066 
 
 
 
 
TABLE 2.3: Ratio of DR mRNA in the mFC over STR.   
The ratio of each receptor in the STR compared to the mFC +/- S.E.M.  is shown at each 
developmental time point for DRD1 (A) and DRD2 (B).  QPCR values for each receptor 
were normalized to the control genes beta actin and 18S rRNA, and averaged from five 
samples per developmental time point.  Unpaired t-tests were used to analyze the 
difference between receptor expression levels in the two brain regions. 
 
A. DRD1 Developmental timepoint STR/mFC t-test 
 E15 0.58 ± 0.10 0.0649 
 E17 3.24 ± 0.66 0.0007 
 E19 6.87 ± 1.34 0.0011 
 E21 3.57 ± 0.74 0.0078 
B. DRD2    
 E15 1.29 ± 0.28 0.4564 
 E17 7.83 ± 0.56 0.0002 
 E19 18.57 ± 2.19 0.0001 
 E21 7.05 ± 1.62 0.0017 
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FIGURE 2.4: DR mRNA expression measured by in situ hybridization and QPCR. 
Densitometric analyses of in situ hybridization results for DRD1 and DRD2 reveals 
significant increases in mFC (A) and STR (B) in a preliminary statistical analysis.  
Shown are the levels of intensity of antisense probes, normalized to the background 
signal generated by sense probes from an adjacent section.  N=12-17 area measurements 
in 2 slices per time point.  QPCR was used to measure mRNA transcript levels of DRD1 
and DRD2 in samples from mFC (C) and STR (D).  Values were normalized to the 
control genes beta actin (ACTB) and 18S rRNA.  Inserts: Magnification of expression 
levels at E15.  n=5 samples/time point.  *p<0.05, **p<0.01, *** p<0.001 in the 
comparison of DRD1 to DRD2 at individual time points; mean ± SEM.  Brackets around 
asterisks denote that these data are semiquantitative.  Paired t-tests were used in (C) and 
(D). 
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Neurons from both brain regions were isolated at two time points, E15 and E18, and 
grown for 72 hours to ensure a stable baseline following the disruption during 
dissociation.  Dissociation causes the release of metabolites that lead to the activation of 
signal transduction pathways which could mimic DR-mediated signaling pathways.  
After 72 hours in culture neurons have re-grown their processes and established synaptic 
connections.  The embryonic time points were chosen to examine the ability of DRs to 
activate second messenger pathways before and after DA fibers have reached the mFC 
and STR.  DA fibers are not reaching to the mFC at E15, but will have arrived at the 
subplate and intermediate zone of the mFC at E18 (Verney et al., 1982, Berger et al., 
1983, Kalsbeek et al., 1988).  In the STR, DA fibers are starting to innervate at E15 with 
a high density observed at E18 (Verney et al., 1982, Berger et al., 1983, Kalsbeek et al., 
1988).   
Initially, we examined the expression of DR mRNAs during each day in culture.  
In mFC neurons plated at E15, we observed a significant induction of DRD1 mRNA over 
time in culture (F5,11=149.7, p<=0.0001), while the change in DRD2 mRNA was much 
smaller, though still significant over time (F5,11=8.4, p<=0.0017), (figure 2.5A).  A 
multivariate ANOVA showed significant differences between DRD1 and DRD2 during 
time in vitro (F5,11=70.3, p<=0.0001; repeated measure [DRD1, DRD2] x day in vitro).  
In STR cultures plated at E15, both DRD1 (F5,12=45.2, p<=0.0001) and DRD2 
(F5,12=60.3, p<=0.0001) mRNAs were induced rapidly (figure 2.5B), and multivariate 
ANOVA showed significant differences between DRD1 and DRD2 during time in vitro 
(F5,12=10.4, p<=0.0005; repeated measure [DRD1, DRD2] x day in vitro).  mFC  
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FIGURE 2.5: DR mRNA expression in mFC and STR neuronal cultures increases 
over time. 
The developmental trajectory of mRNA transcript levels of DRD1 and DRD2 was 
examined in primary culture from mFC (A) and STR (B) plated at E15, and primary 
culture from mFC at E18 (C).  DIV = day in vitro starting 24 hours after plating as DIV 
1.  Values were normalized to the control genes beta actin (ACTB) and 18S rRNA.  Data 
mean ± SEM; paired t-tests: *p<0.05, **p<0.01; n=3 per time point.  Expression levels 
for both DRs were significantly altered over time in all experiments (see ‘Results’). 
 
neurons plated at E18 had a much larger induction of DRD2 mRNA than on E15 
(F3,8=18.8, p<=0.0006) (figure 2.5C). 
 
Activation of DRs in embryonic cultures regulates the phosphorylation status of 
second messenger molecules 
 
Cultures were treated for 15-minutes with either the DRD1 agonist SKF82958 or 
the DRD2 agonist PPHT, and the phosphorylation status of the second messenger 
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proteins CREB, ERK1/2, and GSK3β was assessed with western blots (figure 2.6 and 
2.7).  In E15 cultures, activation of DRD1 was observed in both brain regions (figure 
2.6).  SKF82958 increased ERK1/2 phosphorylation in the mFC at this early time point 
(t(20)=2.6, p<=0.016), whereas in the STR CREB phosphorylation (t(18)=2.6, p<=0.02), 
ERK1/2 phosphorylation (t(15)=3.6, p<=0.0027) and GSK3β phosphorylation (t(18)=3.8, 
p<=0.0015) were increased.  In E18 cultures, SKF82958 increased CREB 
phosphorylation in the mFC (t(31)=2.2, p<=0.033), and STR (t(22)=2.9, p<=0.0089), as 
well as ERK1/2 phosphorylation in the mFC (t(30)=2.8, p<=0.0082), and STR 
(t(24)=2.2, p<=0.038).  Interestingly, the striatal data did not survive multiple-
comparison corrections (Benjamini and Hochberg, 1995), though it is well-known that 
both CREB and ERK1/2 do get phosphorylated in STR cultures from E18 in response to 
DRD1 stimulation (Konradi et al., 1996a, Rajadhyaksha et al., 1998, Brami-Cherrier et 
al., 2002, Dudman et al., 2003).  GSK3β phosphorylation status was unaffected in either 
brain region in E18 cultures.   
DRD2 activation by the agonist PPHT decreased GSK3β phosphorylation in E15 
cultures in both the mFC (t(16)=2.4, p<=0.027) and STR (t(7)=3.6, p<=0.0085; mFC data 
do not survive multiple-comparison corrections), as well as in E18 cultures (mFC: 
t(10)=6.2, p<=0.0001; STR: t(7)=2.4, p<=0.0494; STR data do not survive multiple-
comparison corrections), (figure 2.7).  PPHT also decreased CREB phosphorylation in 
the mFC at E18 (t(19)=4.0, p<=0.0007), and ERK1/2 phosphorylation in the STR at both 
time points (E15: t(7)=3.0, p<=0.020; E18: t(6)=3.3, p<=0.017; STR data at E18 do not 
survive multiple-comparison corrections).   
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The specificity of DR activation was assessed by co-treatment of E18 mFC 
neurons with the DRD1 antagonist SCH23390, and the DRD2 agonist PPHT.  
Antagonism of the DRD1 receptor in conjunction with DRD2 stimulation did not change 
PPHT-mediated dephosphorylation of GSK3β (F(3,8)=7.5, p=0.0104), (figure 2.8).  Post 
hoc t-tests showed a significant difference between DMSO-control and PPHT (t(4)=4.6, 
p<0.0103) as well as DMSO-control and PPHT pretreated with SCH23390 (t(4)=3.6, 
p<.0234) but not between DMSO-control and SCH23390 (t(4)=1.7, p<0.1556).    
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FIGURE 2.6: DRD1-mediated activation of signal transduction pathways in 
embryonic neuronal cultures from the rat mFC and STR. 
Phosphorylation of CREB (A, B), ERK1/2 (C, D), and GSK3β (E, F) was measured in 
embryonic neurons from mFC (A, C, E) or STR (B, D, F) at E15 and E18 in response to 
15-minute treatments with the DRD1 agonist SKF82958.  All neurons were cultured for 3 
days.  Bands were normalized to total protein on the membrane.  Representative blots are 
shown beneath each histogram.  Data mean ± SEM; t-tests: * = p<0.05, ** = p<=0.01.  
N=10-14 per group.   
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FIGURE 2.7: DRD2-mediated activation of signal transduction pathways in 
embryonic neuronal cultures from the rat mFC and STR. 
Phosphorylation of CREB (A, B), ERK1/2 (C, D), and GSK3β (E, F) was measured in 
embryonic neurons from mFC (A, C, E) or STR (B, D, F) at E15 and E18 in response to 
15-minute treatments with the DRD2 agonist PPHT.  All neurons were cultured for 3 
days.  Bands were normalized to total protein on the membrane.  Representative blots are 
shown beneath each histogram.  Data mean ± SEM; t-tests: * = p<0.05, ** = p<=0.01, 
*** = p<= 0.001.  N=4-12 per group. 
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FIGURE 2.8: PPHT mediated activation of GSK3β  is specific for DRD2. 
Co-treatment of E18 mFC neuronal cultures for 15 minutes with the potent DRD2 agonist 
PPHT and the DRD1 antagonist SCH23390.  Antagonism of DRD1 in conjunction with 
PPHT did not affect PPHT-mediated activation of GSK3β.  Bands were normalized to ß-
actin.  Representative blots are shown beneath histogram.  Data mean ± SEM; t-tests: * = 
p<0.05.  N=3 per group. 
 
 
Discussion: 
 The expression pattern and signaling properties of DRs in the rat brain change 
considerably during embryonic development, with unique developmental trajectories of 
mFC and STR.  Whereas the mFC had higher levels of DRD1 than DRD2 mRNA, the 
opposite pattern was seen in the STR.  At E15, expression levels of DRs were low in both 
brain regions, but increased steadily over the course of embryonic development, reaching 
higher levels in the STR than in the mFC.  The DR expression data agree with trends 
reported in a previous study in the murine brain but are not fully comparable as the 
murine study had somewhat different time points (Araki et al., 2007).  We furthermore 
45 
extend the previous study by showing that DRD1 and DRD2 are functional by E15, and 
by providing a detailed description of DR expression at time points between E15 and 
birth. 
DR expression rose sharply during mid gestation in both the mFC and STR.  DRs 
in the mFC exhibited the greatest rate of change from E19 to E21, concurrent with the 
arrival of DA fibers at the subplate and intermediate zone of the mFC at E18 (Verney et 
al., 1982, Berger et al., 1983, Kalsbeek et al., 1988) and the innervation of the mFC at 
E20 (Van den Heuvel and Pasterkamp, 2008).  The slope of DR mRNA expression in the 
STR was greatest from E17 to E19, as DA fibers innervate the STR.  This pattern of 
expression suggests that DR mRNA transcripts are timed with the arrival of midbrain DA 
efferents.   
To examine if DR mRNA expression in cortical and striatal neurons depends on 
DA axon innervation, we measured levels of DR mRNAs in cultured neurons isolated at 
either E15, before DA fibers innervate these areas or at E18, during innervation, and 
grown for 3 days in vitro.  Similar to tissue, mRNA levels of both DRs increased steadily 
in the mFC and the STR, though the induction of DRD2 mRNA in the mFC was small 
when cultures were started at E15 and larger in E18 cultures.  Since expression and 
functional activation of both DRs was detected at E15, DA axon innervation does not 
seem to be required for DR expression.   
Causes for the moderate induction of DRD2 mRNA at E15 could include the need 
for external growth or guidance factors, absence of glial support in the cultures, missing 
environmental cues or an underrepresentation of DRD2 expressing neurons in the mFC at 
E15.  At E15 the cortex consists of a thin layer of pre-plate cells, and only a subset of the 
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DRD2-positive neurons may have matured (Kriegstein et al., 2006).  Birth of the 
remaining DRD2 population may occur between E15 and E19, thus accounting for the 
larger induction of DRD2 mRNA in E18 cultured neurons.   
DRD1 agonists activate PKA and facilitate the phosphorylation of CREB and 
ERK1/2 (Valjent et al., 2000, Dudman et al., 2003).  DRD1 and DRD2 have opposing 
effects on the Akt second messenger pathway and on GSK3β  phosphorylation: DRD1 
agonists cause phosphorylation of GSK3β,  while DRD2 agonists cause 
dephosphorylation of GSK3β (Iwakura et al., 2008, Beaulieu et al., 2009, Beaulieu and 
Gainetdinov, 2011, Souza et al., 2011).  The phosphorylation patterns of CREB, ERK1/2 
and GSK3β were used to examine if DRs were functionally coupled to signal 
transduction pathways in embryonic neurons.  In E15 cultures of the mFC, DRD1 was 
coupled to ERK1/2 phosphorylation.  Coupling of DRD1 pathways was even stronger in 
mFC neurons cultured at E18, causing both CREB and ERK1/2 phosphorylation.  In the 
STR, coupling of DRD1 to CREB and ERK1/2 signal transduction pathways was evident 
in neurons cultured at either E15 or E18.  These findings are in agreement with studies 
that have shown cocaine-mediated phosphorylation of ERK1/2 exclusively in DRD1-
expressing neurons, and inhibition of amphetamine-mediated CREB, ERK1/2, and Akt 
phosphorylation after pretreatment with the DRD1 antagonist SCH23390 (Bertran-
Gonzalez et al., 2008, Shi and McGinty, 2011). 
DRD2 activation with PPHT led to dephosphorylation of GSK3βin both brain 
regions as early as in E15 cultures.  PPHT mediated signaling was mediated by DRD2 
and was not affected by a DRD1 antagonist.  Inhibition of CREB phosphorylation by 
PPHT was observed in the mFC in E18 cultures, and of ERK1/2 phosphorylation in the 
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STR in E15 and E18 cultures.  This inhibition might have resulted from the inhibitory 
action of DRD2 on PKA pathways (Enjalbert and Bockaert, 1983) or an interaction of 
AKT with signal transduction pathways regulating CREB and ERK1/2 phosphorylation.  
The data indicate that DR mRNA expression as well as activation of DR signal 
transduction pathways can be induced in the absence of DA innervation, suggesting an 
internal timing mechanism of DR expressing neurons in mFC and STR.   
Many of the previous studies that have examined DR-mediated modulation of 
Akt- GSK3β activity were carried out in STR tissue or cultured neurons (Beaulieu et al., 
2007, Iwakura et al., 2008).  We present evidence that DRD2 activation increases GSK3β 
activity in the mFC as well as the STR. 
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CHAPTER III 
 
DOPAMINE RECEPTOR STIMULATION DISRUPTS NETRIN-1 AXON 
GUIDANCE IN CORTICAL NEURONS 
 
 
Abstract 
Schizophrenia is a neurodevelopmental disorder with increased activity of the dopamine 
system, decreased activity of the glutamate system and reduced function of the medial 
frontal cortex (mFC). Dopamine receptors (DR) are active in the mFC during the 
formation of neural circuits in embryogenesis.  Netrin-1 is a bifunctional secreted axon 
guidance molecule with stage-dependent attractant or repellant properties in the 
developing cortex. We hypothesized that increased DR activity in the mFC during 
embryogenesis influences the response to netrin-1, thus linking dopamine hyperactivity 
to abnormal axonal pathway formation of glutamatergic cells and reduced function of the 
mFC.  In primary neuronal cultures and neuronal tissue outgrowth assays of the rat mFC 
we found that DR agonists prevented the attraction of mFC axons toward a source of 
netrin-1, by modulating the expression of netrin-1 receptors.  The results suggest that 
abnormal DR activity during embryogenesis can impact neuronal circuit formation in the 
mFC and could provide a mechanism for the developmental origin of schizophrenia. 
 
Introduction: 
Schizophrenia (SZ) is characterized by decreased glutamate activity in the frontal 
cortex (FC) caused by neuronal miswiring during early brain development (Marek et al., 
Volk and Lewis). Dopamine (DA) D2 receptor (DRD2) antagonists improve the positive 
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clinical symptoms of SZ, suggesting a connection between a hyperactive DA system and 
a hypoactive glutamate system in SZ (Seeman, 2009). In support of this notion, agents 
that increase the activity of the dopaminergic system as well as agents that decrease the 
activity of the glutamate system can evoke psychotic symptoms in previously healthy 
individuals (Flaum and Schultz, 1996, Coyle, 2006).   
DA receptors (DRs) are expressed early in the developing rodent medial FC 
(mFC), (Sales et al., 1989, Schambra et al., 1994, Araki et al., 2007, Sillivan and 
Konradi, 2011) and influence developmental processes such as cell proliferation, 
migration, and neurite outgrowth (Zhang and Lidow, 2002, Ohtani et al., 2003, Popolo et 
al., 2004, Crandall et al., 2007, McCarthy et al., 2007, Collo et al., 2008, Donohoe et al., 
2008). DRs regulate the synthesis and activity of growth factors and their receptors 
during brain development (Alberch et al., 1991, Mena et al., 1998, Dawson et al., 2001, 
Guo et al., 2002, Iwakura et al., 2008). Unphysiological activation of DRs during brain 
development, such as through cocaine exposure, alters dendrite morphology and 
structural proteins that regulate the actin cytoskeleton (Harvey et al., 2001, Stanwood et 
al., 2001).  
Netrin-1 (Ntn-1) is a bifunctional secreted axon guidance factor with stage-
dependent attractant or repellent properties (Serafini et al., 1996, Hong et al., 1999).  
Homodimers of the receptor deleted in colorectal cancer (DCC) attract growth cones 
toward Ntn-1, while heterodimers of DCC and the uncoordinated-5c receptor (UNC5C) 
guide growth cones away from Ntn-1 (Lai Wing Sun et al., 2011). Although components 
of DR-mediated signaling cascades, including protein kinase A, calcium, and cyclic 
nucleotides, have been shown to modulate the response to axon guidance molecules such 
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as Ntn-1 (Bouchard et al., 2004, Wen et al., 2004, Gomez and Zheng, 2006, Piper et al., 
2007), a direct involvement of DRs in axon guidance events has not been studied.   
Ntn-1 receptors are expressed in regions that receive DA innervation and, in adult 
rodents, are regulated by amphetamine administration (Gad et al., 1997, Shu et al., 2000, 
Finger et al., 2002, Yetnikoff et al., 2007). We hypothesized that abnormal DR activity in 
the fetal brain influences the development of glutamatergic axonal pathways in the FC, 
which could have long-term effects on the establishment of their connection patterns. An 
investigation of this theory could clarify if a hyperactive DA system during development 
could contribute to the miswiring of glutamate neurons observed in SZ.  It would 
incorporate the most salient observations in SZ, DA hyperactivity, glutamate 
hypoactivity, abnormal functional integration of brain processes and a 
neurodevelopmental component (Lewis and Levitt, 2002, Snitz et al., 2005, Marek et al.) 
Here, we examined the effects of DA hyperactivity on ntn-1-mediated axon 
guidance in the rat mFC by selective stimulation of DRD1 and DRD2.  We show that 
stimulation of either DR subtype diminishes a growth cone’s attraction to ntn-1.   The 
results demonstrate that DR hyperactivity in early brain development could contribute to 
the etiology of SZ.   
 
Material and Methods: 
Animals 
 All animals were housed and maintained in accordance with the policies of 
Vanderbilt University, which is accredited by the Association for the Assessment of 
Accreditation of Laboratory Animal Care. Timed-pregnant female Sprague-Dawley rats 
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(Charles River, Wilmington, MA) were anesthetized with pentobarbital (65mg/kg, 
Sigma, St. Louis, MO) and embryos were removed and washed in sterile phosphate 
buffered saline (PBS). 
 
RNA probe synthesis and in situ hybridization 
 Digoxigenin-labeled probe synthesis and hybridization were performed as 
previously described (Sillivan and Konradi, 2011).  The list of primer pairs used for the 
probe synthesis is shown in table 3.1. Images were captured using Stereo Investigator 
software (MBF BioScience, Williston, VT). 
 
Primary neuronal cultures  
 mFC cells from E15 embryos were cultured as previously described (Sillivan and 
Konradi, 2011).  For quantitation of the trajectory of netrin-1 receptors in culture, cells 
were grown for 1-5 days without drug treatments.  For stimulation of DRs, cells were 
grown for 72 hours in vitro and treated for 1-4 hours with the DRD1 agonist (+)-SKF 
82958 hydrobromide, the DRD2 agonists (+)-quinpirole HCl and (±)-PPHT 
hydrochloride (N-0434), or the partial DRD1/DRD2 agonist R-(-)-apomorphine 
hydrochloride (Sigma). 
QPCR  
 RNA extraction, cDNA synthesis, and QPCR were performed with cultured 
neurons and tissue from the mFC as previously described (Sillivan et al., 2011).  Tissue 
was collected from E15, E17, E19, and E21 embryos and frozen at -80°C until RNA 
extraction. Values were normalized to the internal controls beta actin, 18s RNA, and 
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general transcription factor IIB. Primer pair sequences are listed in table 3.1.  For 
individual developmental trajectories of DCC, and UNC5C, analysis of variance 
(ANOVA) was used to determine statistical significance and repeated measures 
multivariate ANOVAs were used to compare both receptors over time.  For DR 
stimulation time courses, ANOVAs were used and post-hoc analyses were performed by 
comparing each treatment to an untreated control using Dunnett’s test to correct for 
multiple comparisons.  GraphPad InStat software (GraphPad, La Jolla, CA) was used for 
statistical analyses.     
 
Western Blotting  
 Primary neuronal cultures from E15 mFC cells were grown for 1-5 DIV, 
harvested in 1X Laemmli buffer and sonicated. Western blotting was performed as 
previously described (Sillivan and Konradi, 2011) with the following antibodies: anti-
DCC (BD Pharmingen, San Diego, CA) 1:4000, anti-UNC5C (R&D Systems, 
Minneapolis, MN) 1:4000, and anti-actin (Sigma) 1:120,000. Proteins of interest were 
normalized to total protein. 
 
Immunohistochemistry 
 E15 mFC neurons were grown for 3 DIV on coated slide chambers and washed 
briefly with 1X PBS.  Cells were fixed with 4% paraformaldehyde (PFA) for 30 minutes 
at room temperature, permeabilized with .1% Triton for 10 minutes, and then incubated 
in 4% horse serum blocking solution for 2 hours.  Primary antibodies were diluted in 
blocking solution and incubated with cells overnight at 4°C on a rocking platform.  The 
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following primary antibodies were used: anti-DCC (1:1000); anti-UNC5C (1:1000), anti-
dopamine receptor (DRD1) (Sigma) (1:500); and anti-dopamine receptor 2 (DRD2) 
(Millipore, Billerica, MA) (1:500).  The specificity of DR antibodies has been reported 
elsewhere (Lee et al., 2004).  Excess primary antibody was removed with four 10-minute 
PBS washes at room temperature.  Cy-conjugated secondary antibodies (Jackson 
ImmunoResearch Laboratories, West Grove, PA) were diluted in blocking solution and 
incubated with cells for 2 hours at room temperature.  Slides were washed four more 
times in PBS then dried briefly in a dark container.  Pro-gold anti-fade mounting media 
(Invitrogen) was applied to prevent fluorescent signal from fading.  Cells were imaged 
using a 63X oil immersion lens on a Leica LSM510M inverted confocal microscope at 
the Vanderbilt Cell Imaging Resource Core. 
 
Explant Assays 
 HEK293T cells that constitutively express Ntn-1 and GFP or the vector backbone 
only, supplied by Jane Wu (Liu et al., 2004), were grown for several days to create 
“hanging drops” of concentrated cells. HEK293T cell drops were placed in 75 µl of 
Matrigel (BD Biosciences) in a culture dish fitted with a microscope slide (MatTek, 
Ashland, MA), allowing secreted Ntn-1 to create a gradient in the collagen matrix 
(Bonnin, 2010).  E15 mFC explants were obtained as described above and placed around 
the HEK293T cells.  Neurobasal medium supplemented with B-27 and N-2 was added 30 
minutes after the collagen solidified, and 20µM SKF82958 or quinpirole was added 2 
hours after plating explants.  Explants were grown for 48 hours then fixed with 4% PFA 
overnight at 4°C.  To visualize neurites, cultures were blocked for 2 hours in 2% BSA/ 
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.1% triton, then incubated with mouse anti-TUJ1-Alexa488 (beta tubulin) antibody 
(Covance, Princeton, New Jersey) diluted 1:1000 for 24 hours at 4°C.  Cultures were 
washed 4 times in PBS and imaged using a fluorescent microscope. 
 
Analysis of explant cultures: 
 Image J software (NIH, Bethesda, MD) (Abramoff, 2004) with Neuron J plugin 
(Meijering, 2010) was used to analyze explant images.  All images were blind-scored by 
3 independent investigators to determine the direction of growth in response to HEK293T 
cells and Pearsson chi-square (χ2) correlation was used to determine statistical 
significance.  For axon bundle density, the number of axons per quadrant (proximal, 
distal, symmetrical) was calculated at a distance of 100µm from the edge of the explant.  
The ratio of [proximal-distal axons/total axons] was used as a measure of axon guidance 
while the ratio of [proximal + distal axons/total axons] was used as a measure of 
outgrowth.  An ANOVA was performed with all treatment conditions combined and the 
Tukey-Kramer HSD Multiple Comparisons Test was used for post-hoc analysis. 
 
Microfluidic devices  
 Devices were fabricated and prepared as previously described, with modification 
(Majumdar et al., 2011).  Each device consisted of two chambers separated by a 100µm 
polydimethylsiloxane (PDMS) wall with microgrooves at the bottom.  After equilibration 
with cell culture media, ~100,000 E15 mFC neurons were added to one chamber.  24 
hours later, 10ng/ml recombinant Ntn-1 protein (R & D Systems) was added to the other 
chamber, with DR agonists if needed.  The neuronal chamber contained a slightly higher 
55 
volume of media to ensure that Ntn-1 protein only diffuses through the microgrooves to 
form a concentration gradient, similar to the approach developed by Taylor et al. (Taylor 
et al., 2005).  After 48 hours in culture, neurons were fixed with 4% PFA/ 0.6M sucrose 
overnight at 4°C.  For visualization of neuronal processes that extended across the 
microgrooves from one side of the device to the other, cells were stained as described 
above with anti-beta tubulin antibody and imaged using a fluorescent microscope.  The 
length of axons that entered the microgrooves was measured using Image J Software and 
the Neuron J plugin.  The average of the 15 longest neurites was calculated per slide and 
normalized to the percentage of growth in untreated slides.  Kruskal-Wallis 
nonparametric ANOVAs were used to determine statistical significance by comparing all 
treatment groups and Dunn’s Multiple Comparisons Test was used for post-hoc analysis. 
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 TABLE 3.1: List of primer sequences used for probe synthesis (A) and QPCR (B).  F/R 
indicates primer direction, forward or reverse. 
 
A) Primers used to synthesize RNA probes 
Name F/R sequence 
F 5'- TCCCCAAGCCTGCCATCCCA-3' DCC outer 
primer 1 R 5'-GCATAGGCAGGGGGTTCCCA-3' 
F 5'-GGGTGAGATGGAAACACTGG-3' DCC outer 
primer 2 R 5'-TGAGAACTCGACTCCAGCCT-3' 
F 5'-AGCAGCGAAGAAGCCCCCAGCA-3' DCC outer  
primer 3 R 5'-AAAGGCGGAGCCCGTGATGGCA-3' 
F 5'-CGTGCGCATTGCGTATCTGC-3' UNC5C outer  
primer 1 R 5'-GGGCTGGGTTGGTGCAGGTT-3' 
F 5'-AGACTCTCAGACCCTGCTGA-3' UNC5C outer  
primer 2 R 5'-AGGGCATCCTGTGTGTCATC-3' 
F 5'-TCCACAACCTGCGCCTCTCAA-3' UNC5C outer  
primer 3 R 5'-GGGGCATCCAGGCTGCTACA-3' 
F 5'-AAGCATTTAGGTGACACTATAAGCATCCTCCCTTCTGCTCCCA-3' DCC nested  
primer 1 R 5'-AAGCTCTAATACGACTCACTATAGGGTCAGGCTGAGTGGCCACCTTGA-3' 
F 5'-AAGCATTTAGGTGACACTATATTCACAGGATTGGAGAAGGG-3' DCC nested 
primer 2 R 5'-AAGCTCTAATACGACTCACTATAGGGATAAGGGCTGCCAACACCAT-3' 
F 5'-AAGCATTTAGGTGACACTATAAGCCTGTGTGCGGCCAACTC-3' DCC nested 
primer 3 R 5'-AAGCTCTAATACGACTCACTATAGGGTGGCTGGATCCTCTGTTGGCT-3' 
F 5'-AAGCATTTAGGTGACACTATAAGTGCCGGCCACCTGAAGGGAT-3' UNC5C nested 
primer 1 R 5'-AAGCTCTAATACGACTCACTATAGGGCACAGACCATTCTGCCCAGGTG-3' 
F 5'-AAGCATTTAGGTGACACTATACCTAACACCGAGGACTGGAA-3' UNC5C nested 
primer 2 R 5'-AAGCTCTAATACGACTCACTATAGGGTACTCCAGGGAAGAGCAGCA-3' 
F 5'-AAGCATTTAGGTGACACTATAACCACATCTGGAGTGGCTCTCA-3' UNC5C nested 
primer 3 R 5'-AAGCTCTAATACGACTCACTATAGGGTGCCGGATAGGAAGAGGGATGC-3' 
B) Primers used for QPCR 
Name F/R sequence 
F 5'-TGGCTCAGCGTGTGCCTACC-3' 18s RNA 
R 5'-TAGTAGCGACGGGCGGTGTG-3' 
F 5'-CTATGAGCTGCCTGACGGT-3' Beta actin 
R 5'-TGGCATAGAGGTCTTTACGGA-3' 
F 5' - CTATGCAAATGGTCCGGTTC - 3' DCC 
R 5' - GAGCACTTGGCACATCTGAA - 3' 
F 5' - TGCGATAGCTTCTGCTTGTC - 3' GTF2B 
R 5' - TCAGATCCACGCTCGTCTC - 3' 
F 5' - TGTTGTGGTTGTTGGAGAGG - 3' UNC5C 
R 5' - AGGGCATCCTGTGTGTCATC - 3' 
 
Results: 
Expression of netrin-1 receptors in the developing rat cortex 
 mRNA expression of the Ntn-1 receptors, DCC and UNC5C, was examined in the 
mFC of developing rat embryos (figure 3.1).  Strong expression of DCC was found 
throughout the cortical plate at E15 and a distinct medial to lateral gradient of DCC was 
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found at E18 (figure 3.1A, 3.1B). UNC5C expression was extremely low in the 
developing mFC with an increase between E15 and E18 (figure 3.1C, 3.1D).  QPCR was 
used to quantify mRNA expression patterns of DCC and UNC5C in mFC tissue.  From 
E15 to E21 mRNA levels of both receptors were significantly changing (DCC: 
F[3,16]=8.96, p<=0.0010; UNC5C: F[3,16]=10.61, p<=0.0004) (figure 3.1E).  At early 
stages of gestation, levels of DCC were much higher than levels of UNC5C but the ratio 
of DCC to UNC5C decreased with age (table 3.2).  A multivariate ANOVA showed 
significant differences between DCC and UNC5C over time (F[3,16]=9.98, p<=0.0006; 
repeated measure [DCC, UNC5C] x embryonic day).  
To determine whether these expression patterns exist in vitro, we cultured mFC 
neurons from E15 embryos for 1-6 days and found similar expression patterns for DCC 
(F[5,11]=13.81, p<=0.0002) as well as UNC5C (F[3,11]=101.80, p<=0.0001) over time 
as well as in relation to each other (F[5,11]=18.40, p<=0.0001; repeated measure [DCC, 
UNC5C] x embryonic day) (figure 3.1E).  Protein expression of Ntn-1 receptors in mFC 
neuronal cultures coincided with the reported mRNA expression, with a peak of DCC 
protein at E18, shortly after the peak of mRNA, while levels of UNC5C protein were 
more evenly expressed (figure 3.1F).  
 
Colocalization of DRs and netrin-1 receptors in cortical neurons  
 Previously we reported the expression profile of DRD1 and DRD2 in the mFC 
throughout embryonic development (Sillivan et al., 2011).  We verified colocalization of 
Ntn-1 receptors and DRs, with double immunocytochemistry in E15 mFC cells, cultured 
for 3 DIV (figure 3.2).    
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FIGURE 3.1: Expression of Ntn-1 DCC and UNC5C in the developing mFC.  
In situ hybridization of DCC (A, B) and UNC5C (C, D) in the mFC at embryonic day 15 (A, C) and 
18 (B, D).  High levels of DCC are seen along the midline in the mFC and septum, while UNC5C is 
expressed at much lower levels.  Scale bar = 500µm.  2-3 animals were examined per timepoint.  E.  
Similar trajectories of DCC and UNC5C mRNA expression in the mFC in embryonic tissue and 
primary neuronal culture.  Levels of mRNA transcripts were measured by QPCR. Neurons were 
isolated at E15 and cultured for 1-6 days.  Mean +/- S.E.M. N=3-5 per timepoint.  F.  Protein 
expression of DCC and UNC5C in neurons cultured at E15. Mean +/- S.E.M. N=3 per timepoint. 
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Netrin-1 attracts neurites from explants of the mFC  
 To examine the functional significance of DR activity in Ntn-1 receptor 
expressing cells, we used an in vitro axon guidance assay (figure 3.3).  HEK293T cells 
expressing Ntn-1 attracted mFC explants while HEK293T cells with the vector backbone 
only (parent) did not (figure 3.3A, 3.3B). Treatment with 20µM of the DRD1 agonist 
SKF82958 or the DRD2 agonist quinpirole disrupted Ntn-1 mediated attraction, resulting 
in more neurite outgrowth in the symmetrical and distal quadrants (figure 3.3C, 3.3D).    
 
DR stimulation disrupts netrin-1 mediated axon guidance 
Three independent investigators without knowledge of treatment examined the 
main direction of neurite outgrowth relative to the HEK cells.  The number of explants 
with neurites growing towards, away or symmetrical, was calculated, as well as the axon 
bundle density in each quadrant (figure 3.4A).  mFC explants displayed significantly 
different outgrowth patterns in the presence of Ntn-1-expressing HEK cells (figure 3.4B).  
A majority of mFC explants placed next to parent HEK293T cells showed symmetrical 
outgrowth, while explants grown with Ntn-1 expressing HEK cells showed preferential 
outgrowth in the direction of the cells (Ntn-1 alone versus parent alone: χ2 =15.74, 
p<.0004, d.f=2).  Stimulation of DRs altered the response of mFC neurites to Ntn-1 
(figure 3.4D; Ntn-1 alone versus Ntn-1 with SKF82958: χ2 =6.82, p<.0330, d.f=2; Ntn-1 
alone versus Ntn-1 with quinpirole: χ2 =10.46, p<.0053, d.f=2), whereas DR agonists did 
not affect outgrowth in explants placed next to the parental cell line (figure 3.4C).  
The number of axon bundles was counted in each quadrant- proximal, distal, and 
symmetrical- at a distance of 100µM from the edge of the explant.   A one-way ANOVA 
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between treatments was conducted to compare the guidance ratio of [proximal-distal/total 
axons] in all conditions.  Ntn-1 significantly affected the percentage of neurites in each 
quadrant, a situation that was blocked by DR agonists (figure 3E, [F[5,132]=3.83; 
p=.0029]),  Post hoc comparisons with the Tukey Kramer HSD test showed that the mean 
ratio for explants cultured with Ntn-1 was significantly different from those cultured with 
the parental cell line, or from those treated with SKF82958 and quinpirole in the presence 
of Ntn-1 cells.  SKF82958- or quinpirole-treated explants cultured with Ntn-1 were not 
significantly different from SKF82958- or quinpirole-treated explants cultured with 
parental cells.  An outgrowth ratio, obtained by calculating [proximal+distal/total axons], 
indicated no significant differences in total axon outgrowth in the proximal and distal 
quadrants between the treatment groups (figure 3F). 
 
DR stimulation reduces axon attraction to netrin-1 
Outgrowth of individual mFC axons was examined using microfluidic chambers 
that allow for the culture of neurons next to a chemoattractive gradient.  The devices 
consist of two chambers linked by microgrooves that permit individual axon growth into 
the other chamber.  Cultures were grown in the absence or presence of recombinant Ntn-
1 protein and/or DR agonists in the adjacent chamber (figure 3.5).  Results were 
consistent with explant experiments, with significant differences observed among the 
treatment groups (KW=60.51, p<.0001 using Kruskal-Wallis test).  Application of 
10ng/ml recombinant Ntn-1 increased the length of axons entering the microwells over 
that of the untreated control, but co-treatment with 20µM SKF82958 or the more potent 
DRD2 agonist PPHT disrupted this effect (figure 3.5G).  Axon length in cultures treated  
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TABLE 3.2: The ratio of DCC:UNC5C mRNA expression in mFC neurons (A) and 
tissue (B). 
 
A) Neurons 
Days PC Ratio DCC/Unc5 Paired T-test 
17 64 0.0035 
19 15 0.0078 
21 8 0.0137 
 
B) Tissue 
Days PC Ratio DCC/Unc5 Paired T-test 
15 16 0.0002 
17 61 0.0015 
19 18 0.0054 
21 8 0.0051 
 
 
 
FIGURE 3.2: Colocalization of DRs and Ntn-1 receptors in mFC neurons. 
Immunocytochemistry of E15 mFC neurons, cultured for 3 DIV, shows that both DRD1 
(A, C) and DRD2 (B, D) colocalize with Ntn-1 receptors DCC (A, B) and UNC5C (C, 
D). Scale bar = 10 µm. 
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FIGURE 3.3: Stimulation of DRs disrupts Ntn-1-mediated attraction in mFC 
explants. 
E15 mFC explants were cultured near Ntn-1-expressing HEK293T cells for 72 hours to 
examine the chemoattractant properties of Ntn-1 in the mFC. A. Explants cultured with 
the parental cell line, which does not express Ntn-1, display symmetrical outgrowth.  B. 
Ntn-1 attracts neurites from mFC explants.  More outgrowth occurs in regions proximal 
to the Ntn-1-expressing cells.  Treatment with the DRD1 agonist SKF82958 (C) or the 
DRD2 agonist quinpirole (D) disrupts Ntn-1-mediated attraction in mFC explants.  Scale 
bar = 100 µm.      
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FIGURE 3.4: DR agonists inhibit the attractive properties of Ntn-1 in mFC explants.  
A. Illustration of the strategies used to analyze explant images.  B, C, D. The direction of neurite outgrowth 
with respect to the location of the HEK239T cells was quantified by blind scoring and is depicted as 
percentage of explants that grew towards (white column), symmetrically (grey column), or away (black 
column) from HEK293T cells.  B. mFC explants are attracted to Ntn-1 expressing cells  C.  mFC explants 
cultured with the parental cell line display predominantly symmetrical outgrowth.  D. Treatment with 
20µM of the DRD1 agonist SKF82958 or the DRD2 agonist quinpirole changes the direction of outgrowth 
of mFC neurites in response to Ntn-1.  E, F. Quantification of the number of axon bundles 100µM from the 
explant in the proximal and distal regions, in relation to the HEK293T cells. E. A measure of guidance: the 
ratio of the difference in axon number in proximal versus distal regions divided by the total number of 
axons.  F. Total outgrowth was comparable between all treatments.  The ratio of the sum of proximal and 
distal axons over the total number of axons. Mean +/- S.E.M. *p<.05; ** p<.01; ***p<.001. 
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with DR agonists in the absence of Ntn-1 did not differ from untreated controls (figure 
3.5H). 
 
DR stimulation increases Ntn-1 receptor expression 
Taken together, these results suggest that DR stimulation modifies Ntn-1 
mediated guidance of mFC neurites.  To further examine this finding, we stimulated DRs 
in E15 mFC cultured neurons and measured mRNA levels of the Ntn-1 receptors DCC 
and UNC5C (figure 3.6).  DCC expression was not altered by treatment with DR 
agonists.  Treatment with the DRD1 agonist SKF82958 increased the expression of 
UNC5C, the Ntn-1 receptor involved in repulsion, (F[3,53]=4.05, p=0.0115), and post 
hoc comparisons showed a significant increase after 4 hours (t[15]=2.65, p<.05) (figure 
3.6A).  The DRD2 agonist quinpirole increased UNC5C mRNA levels (F[3,64]=3.00, 
p=0.0368) after 1 hour (t[18]=2.87, p<.05) (figure 3.6B).  The potent DRD2 agonist 
PPHT showed even more robust effects (F[3,71]=5.14, p=.0028), with significant 
increases in UNC5C transcripts after 2 (t[25]=2.44, p<.05) and 4 hours (t[10]=3.50, 
p<.01) (Figure 3.6C).   The partial DRD1/DRD2 agonist apomorphine had an amplified 
effect (F[3,56]=9.37, p=.0001) and large increases in UNC5C transcripts were measured 
at every timepoint (1 hour: t[18]=3.46, p<.01; 2 hours: t[12]=4.60, p<.01; 4 hours: 
t[12]=4.15, p<.01) (Figure 3.6D).  While an ANOVA indicated a significant effect of 
apomorphine on DCC expression (F[3,52]=3.04, p=.0373), no differences were seen with 
post hoc tests. 
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FIGURE 3.5- DR agonists impair Ntn-1-mediated outgrowth.  
Neurons were grown in microfluidic chambers next to Ntn-1 containing medium.  Two 
chambers were separated by 100 µm microwells that allow for axon growth toward Ntn-1 
containing medium.  Individual axon outgrowth was examined in the absence (A,C,E) or 
presence of recombinant Ntn-1 protein (B,D,F). The addition of 10ng/ml recombinant 
Ntn-1 in the adjacent chamber (B) increased axon length over that of the untreated 
control (A) but co-application of Ntn-1 with 20µM SKF82958 (D) or 20µM PPHT (F) 
disrupted this effect, while either agonist alone (C,E) had no effect.  Shown are 
representative photomicrographs for each condition with dotted lines denoting the 
borders of the microwells.  Scale bar = 20µM.  (G,H) Quantification of the average axon 
length in each treatment condition, presented as the % length of axons in untreated slides.  
N= 15 axons per slide X 6 slides per treatment. Mean +/- S.EM. ***p<.001. 
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FIGURE 3.6: DR agonists regulate mRNA levels of Ntn-1 receptors.  
E15 mFC neurons were grown 3 DIV and treated with the DRD1 agonist SKF82958 (A), 
the DRD2 agonists quinpirole (B) and PPHT (C), or the partial DRD1/DRD2 agonist 
apomorphine (D) for 1, 2, or 4 hours.  N= 10-30 per group. Mean +/- S.EM. *p<.05; 
**p<.01.  
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FIGURE 3.7: Model depicting DR modulation of Ntn-1 mediated axon guidance 
mechanisms. 
Cortical neurons are attracted to Ntn-1 when homodimers of DCC are present on the 
surface of the growth cone.  The interaction of DCC with Ntn-1 activates the Rho 
GTPase molecules Cdc42 and Rac1, signaling for an increase in actin polymerization and 
the formation of filopodia and lamellipodia in the direction of the Ntn-1 gradient.  The 
activation of either DRD1 or DRD2 will increase mRNA levels of UNC5C, resulting in 
heterodimers of DCC and UNC5C on the surface of the cell.  Interaction of Ntn-1 with 
UNC5C activates the Rho GTPase RhoA, resulting in growth cone repulsion and 
retraction, signaling for the movement of the growth cone away from Ntn-1 gradients. 
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Discussion: 
SZ is characterized by decreased connectivity and hypofunction of glutamate 
neurons in the mFC (Murray et al., 2008, Seeman, 2009, Marek et al., 2010, Volk and 
Lewis, 2010). Aberrant dopaminergic signaling in the medial frontal cortex (mFC) and 
subcortical regions contributes to the psychotic and negative symptoms, as well as the 
cognitive deficits that characterize the disease (Rapoport et al., 2005, Howes and Kapur, 
2009). The early onset of SZ suggests that abnormal axon pathfinding could occur early 
in the disease and thus contribute to altered circuit formation in the mFC.  We therefore 
examined the hypothesis that an overactive DA system might influence axonal outgrowth 
of glutamatergic neurons in the mFC during early brain development thus causing a 
reduction in neuritic processes and a miswiring of glutamate neurons (McGlashan and 
Hoffman, 2000). As we show here, DA agonists disrupt neuronal attraction of 
glutamatergic axons to the guidance factor Ntn-1.  This observation indicates that 
abnormally high DR activity or exposure to high levels of DR agonists during critical 
developmental periods may derail the proper formation of neuronal circuits and axon 
pathfinding events, with potential long-term effects on brain function.  
Ntn-1 is a chemoattractant for cortical growth cones in the developing rat brain 
(Metin et al., 1997). Attraction to Ntn-1 is mediated by homodimers of DCC receptors 
while growth cone collapse and repulsion of Ntn-1 is mediated by heterodimers of 
UNC5C/DCC receptors (Hong et al., 1999, Lai Wing Sun et al., 2011).  Changes in the 
ratio of DCC to UNC5C during development alter the response to Ntn-1 cues; increasing 
levels of UNC5C expressed and translocated at the growth cone change its response from 
attraction to repulsion (Hong et al., 1999).  This is a proposed mechanism by which 
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axons, initially attracted, can keep growing through regions of high Ntn-1 expression and 
reach their final targets (Kaprielian et al., 2001). Therefore, the timing and titration of 
expression and translocation of both receptors is important, and interference from outside 
sources, such as observed here with DR agonists, can have detrimental consequences on 
normal pathfinding. 
At E15, the time we collected the neurons for culture, the cortex consists of a thin 
layer of cells slated for the deep layers of the mature cortex (Kriegstein et al., 2006).  
During this developmental period, Ntn-1 serves as an intermediate cue for subcortical 
projections of mFC neurons, while soon after it guides callosal projections 
interhemispherically (Richards et al., 1997, Donahoo and Richards, 2009).  Disturbed 
neuronal communication in SZ is observed between the hemispheres as well as in 
cortico-limbic circuits, supporting an involvement of Ntn-1 in the pathology of SZ (Ford 
et al., 2007). 
DA afferents synapse with neurons in the mFC at E20 (Sesack et al., 1995, Carr et 
al., 1999, Carr and Sesack, 2000, Van den Heuvel and Pasterkamp, 2008). Cortical 
growth cones express functional DRs in E15 mFC cultures (Sillivan and Konradi, 2011) 
and DR signaling alters their response to Ntn-1 (this study); this suggests that in vivo, if 
DA afferents release abnormal levels of the amine into this region, Ntn-1-dependent mFC 
axon pathfinding could be disrupted.  Alternatively, hypersensitive DA receptor pathways 
or environmental exposure to DR agonists could disrupt the axon pathfinding of cortical 
neurons.  
Given that DR subtypes are differently coupled to cAMP pathways (Bronson and 
Konradi, 2010), the lack of specificity of DR agonists on modulating axons response to 
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Ntn-1 was surprising. Although in the adult rat brain both DR subtypes are found on 
glutamatergic principal neurons and gamma-aminobutyric acid (GABA) interneurons, 
there are many more glutamatergic DR positive cells in the cortex (Santana et al., 2009).  
In the neuronal outgrowth assays, it is unlikely that a trans-synaptic action via GABA 
neurons of one receptor subtype, and a direct action on glutamate neurons of the other 
receptor subtype occurs.  
Axonal response to Ntn-1 is modulated by intracelllar Ca2+ levels; modest levels 
of calcium promote attraction while excessive or insufficient calcium levels lead to 
repulsion (Gomez and Zheng, 2006). DRD1 activation increases protein kinase A 
activity, allowing calcium to flow into the cell through L-type calcium channels (Konradi 
et al., 1996b, Dudman et al., 2003).  DRD2 receptors inhibit the flow of extracellular 
calcium, but mobilize intracellular calcium and activate phospholipase C pathways 
(Hernandez-Lopez et al., 2000).  Thus activation of both DR subtypes can stimulate 
intracellular calcium signaling and provide a common pathway by which both DRD1 and 
DRD2 agonists change an axon’s response to Ntn-1 (figure 3.7).  
It has previously been shown that activation of serotonin receptors modulates the 
response of thalamocortical axons to Ntn-1 (Bonnin et al., 2007).  These and our 
observations suggest that a general developmental role of modulatory neurotransmitters 
like DA and serotonin is to regulate axon guidance events in the fetal brain.  Aberrant 
activity of these systems during crucial developmental periods could lead to miswiring of 
brain circuitries and later impair cognitive function.  Thus, the hyperactivity of the DA 
system observed in SZ in adulthood might exert its most dramatic influence during early 
brain development. 
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CHAPTER IV. 
 
POSTNATAL COCAINE ADMINISTRATION REGULATES AXON GUIDANCE 
MOLECULES IN THE PFC AND STRIATUM 
 
 
Abstract 
Psychostimulants regulate the abundance of axon guidance molecules and their receptors 
in adult animals but it not known if these effects occur in younger animals during periods 
of axonal pathfinding and synaptogenesis.  Sprague Dawley rats received daily injections 
of cocaine or saline vehicle during two early postnatal (PN) periods: PN10-14 or PN17-
21.  mRNA expression of axon guidance-related genes was measured with QPCR in 
prefrontal cortex (PFC) and striatal (STR) tissue.  PN cocaine exposure regulated the 
expression of Dcc, Sema3c, Nrp1, and Nrp2.  Early exposure to drugs of abuse may 
therefore disrupt the natural trajectory of neuronal circuit formation by regulating the 
abundance of axon guidance molecules and/or their receptors. 
 
Introduction 
Axon guidance molecules (AGM) are expressed in the developing nervous system 
and influence the trajectory of outgrowth and path specification of axonal growth cones 
(Plachez and Richards, 2005).  Directional steering by AGMs guides growth cones to 
their target location where synapse formation occurs (Shen and Cowan, 2010).  AGMs 
can be attractive or repulsive, secreted or membrane-bound, and are divided into four 
major groups: ephrins (Eph receptors), netrins (Dcc/Unc receptors), semaphorins 
(Neuropilin/Plexin receptors), and slits (Robo receptors) (Bashaw and Klein, 2010). 
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Many components of AGM signaling are sensitive to neuronal activities that can 
be modulated by the neurotransmitter dopamine (DA), including membrane 
depolarization, kinase activity, and regulation of levels of calcium and cyclic nucleotides 
(Ming et al., 1999, Nishiyama et al., 2003, Bouchard et al., 2004, Neve et al., 2004, 
Gomez and Zheng, 2006).  In adult animals, the administration of stimulants such as 
cocaine and amphetamine increases dopaminergic tone and regulates the expression of 
axon guidance-related genes (Bahi and Dreyer, 2005, Yetnikoff et al., 2007).  Because 
adult animals are not undergoing axon pathfinding, these drug-induced changes may be 
related to the pathology of addiction.   
It is not known how DA signaling effects axon guidance events in the developing 
brain and very little research has examined the consequences of early life stimulant 
exposure on AGM expression.  Both prenatal and postnatal (PN) cocaine exposure 
increased expression of the eph receptor Ephb1 in the cortex and striatum (STR) 
(Halladay et al., 2000). However, no studies have been carried out to examine the effects 
of stimulant exposure or aberrant DA signaling on other classes of AGMs during the time 
period in which axon guidance is occurring.  In this study, we address this question by 
measuring mRNA levels of guidance-related genes from three different AGM families 
after PN cocaine exposure.        
 
Material and Methods 
Animals 
 All animals were housed and maintained in accordance with the policies of 
Vanderbilt University, which is accredited by the Association for the Assessment of 
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Accreditation of Laboratory Animal Care. Four timed-pregnant female Sprague-Dawley 
rats (Charles River, Wilmington, MA) were received at 18 days post conception and 
individually housed until pups were born.  Weights for each animal were recorded daily 
throughout the duration of the study.  Animals remained with the nursing mother at all 
times, except during drug administration.  
 
Drug administration 
 Cocaine hydrochloride (Sigma; St. Louis, MO) was dissolved in 0.9 % saline and 
administered subcutaneously at 5mg/kg, in a volume of 1µl/g body weight, as shown in 
figure 4.1. 0.9% saline was used for all vehicle injections.  Each animal was injected once 
per day for 5 days during either postnatal week 2 or 3. Animals were divided into one of 
four groups: A) vehicle from PN10 to PN14; B) cocaine from PN10 to PN14; C) vehicle 
from PN17 to PN21; D) cocaine from PN17 to PN21.  Animals were sacrificed by rapid 
decapitation 2 hours after their last injection.  
 
QPCR 
 Brains were flash frozen in methyl butane immediately after removal and stored at 
-80°C.  PFC and STR tissue were dissected from brains using a sliding microtome.  RNA 
extraction, cDNA synthesis, and QPCR were performed as previously described (Sillivan 
et al., 2011), with modifications.  QPCR reactions were performed in a Stratagene 
ThermoCycler (Agilent, Santa Clara, CA) with Bio-Rad SYBR green mastermix (Bio-
Rad, Hercules, CA).  PCR cycling conditions were as follows: an initial step of 95°C for 
5 min, followed by 40 cycles of 94°C for 15s, 55°C for 15s, 72°C for 30s, and data were 
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collected between 78-83°C, depending on primer specificity.  A list of primer sequences 
used can be found in table 4.1.  Genes were chosen for analysis based on previously 
reported findings in the literature.  Values were normalized to the internal controls beta 
(ß)-actin and general transcription factor IIB.  Student’s unpaired t-tests were used to 
determine statistical significance. 
 
 
 
Figure 4.1: Overview of drug paradigm for postnatal cocaine administration. 
Rats received one subcutaneous injection per day of 5mg/ml cocaine or saline vehicle 
during the second PN week (cohort 1), or the third PN week (cohort 2).  Animals were 
sacrificed two hours after the last injection. 
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Table 4.1: List of primer sequences used in QPCR experiments. 
Gene Name Symbol Direction Sequence 
Forward 5' - CTATGAGCTGCCTGACGGT - 3' Beta Actin Actb 
Reverse 5' - TGGCATAGAGGTCTTTACGGA - 3' 
Forward 5' - CTATGCAAATGGTCCGGTTC - 3' Deleted in colorectal 
cancer Dcc Reverse 5' - GAGCACTTGGCACATCTGAA - 3' 
Forward 5'-AGGGTGTTGTCACCAAGAGC-3' Eph receptor B1 Ephb1 
Reverse 5'-CACACCAGGTTGCTGTTCAC-3' 
Forward 5' - TGCGATAGCTTCTGCTTGTC - 3' General transcription 
factor IIB Gtf2b Reverse 5' - TCAGATCCACGCTCGTCTC - 3' 
Forward 5'-CCAATCAGAGTTCCCGACAT-3' Neuropilin 1 Nrp1 
Reverse 5'-AATAGACCACAGGGCTCACC-3' 
Forward 5'-ATGGCTTCAGGTGGATCTTG-3' Neuropilin 2 Nrp2 
Reverse 5'-AACAGCTTTGGCTGCTGAGT-3' 
Forward 5'-TGGTTTCAGTCCCCAAGGAG-3' Semaphorin 3A Sema3a 
Reverse 5'-CATCCCAGGCACAATAAGG-3' 
Forward 5'-GCAAAATGGCTGGCAAAG-3' Semaphorin 3C Sema3c 
Reverse 5'-GGGGTTGAAAGAGCATCGT-3' 
Forward 5' - TGTTGTGGTTGTTGGAGAGG - 3' Unc-5 homolog C Unc5c 
Reverse 5' - AGGGCATCCTGTGTGTCATC - 3' 
 
Results 
Cocaine administration regulates expression of axon guidance genes in the PFC and 
STR  
 Sprague Dawley rats were exposed to cocaine or vehicle during weeks 2 and 3 of 
postnatal development (figure 4.1).  mRNA expression of 7 genes involved in axon 
guidance processes was measured with QPCR after cocaine exposure (figure 4.2 and 
table 4.2).  Cocaine exposure from PN10-14 increased expression of Dcc and Sema3a in 
the PFC but decreased expression of Nrp1 in the STR (figure 4.2A-4.2B).  Cocaine 
exposure from PN17-21 decreased expression of Nrp1 in both brain regions and 
expression of Nrp2 in the STR (figure 4.2C-4.2D).  Dcc expression increased in the STR 
after cocaine exposure from PN17-21 (figure 4.2D).  No changes were seen in Ephb1, 
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Sema3c, or Unc5c expression in after cocaine exposure in either brain region.  A 
summary of gene changes can be found in table 4.3.       
 
 
 
 
Figure 4.2: Postnatal cocaine exposure regulates expression of axon guidance genes 
in the PFC and STR. 
Quantitative PCR measurement of mRNA levels of 7 genes involved in axon guidance 
events after cocaine exposure from PN10-14 (A,B) or from PN17-21 (C,D).  Shown are 
expression levels of cocaine-exposed animals as a percent of the mRNA expression in 
vehicle treated animals.  All values were normalized to the internal controls Actb and 
Gtf2b.  Asterisks denote values significantly different between cocaine exposed and 
vehicle treated animals. PN10-14: vehicle N=12, cocaine N=12; PN17-21: vehicle N=11, 
cocaine N=14.  Error ± SEM. *p<.05; p<.01. 
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Table 4.2: mRNA analysis of axon guidance-related proteins. 
Average mRNA copy numbers in PFC (A) and STR (B) tissue ±SEM.  Values were 
normalized to the internal controls Actb and Gtf2b.  Asterisks denote values significantly 
different between cocaine exposed and vehicle exposed animals.  *p<.05; p<.01. 
 
A. PFC 
Gene Vehicle PN10-14 Cocaine PN10-14 Vehicle PN 17-21 Cocaine PN17-21 
DCC 1.00±.03     1.19±.05 ** 1.25±.05 1.18±.04 
EphB1 1.05±.02 1.02±.03 1.07±.03 1.10±.03 
NRP1 1.35±.04 1.35±.06 1.35±.06  1.15±.05* 
NRP2 1.09±.07 0.93±.09 1.18±.03 0.92±.11 
Sema3A 1.20±.03 1.18±.04 1.24±.04 1.17±.06 
Sema3C 1.02±.04    1.19±.04** 1.16±.04 1.18±.04 
UNC5C 1.08±.05 1.10±.05 1.33±.08 1.38±.06 
 
B. STR 
Gene Vehicle PN10-14 Cocaine PN10-14 Vehicle PN 17-21 Cocaine PN17-21 
DCC 1.28±.09 1.16±.10 1.12±.03   1.24±.04* 
EphB1 1.31±.07 1.15±.07 1.13±.03 1.13±.05 
NRP1 1.17±.04 1.02±.07 1.25±.11   0.92±.07* 
NRP2 1.07±.12    0.61±.08** 1.23±.12   0.74±.12* 
Sema3A 1.04±.04 1.16±.06 1.36±.08 1.25±.05 
Sema3C 1.09±.12 1.24±.20 1.37±.09 1.22±.06 
UNC5C 1.32±.08 1.21±.05 1.63±.05 1.62±.09 
 
 
 
 
 
Table 4.3: Summary of gene changes in the PFC and STR after postnatal cocaine 
exposure. 
Gene PFC: PN10-14 PFC: PN17-21 STR: PN10-14 STR: PN17-21 
Dcc increased no change no change increased 
Ephb1 no change no change no change no change 
Nrp1 no change decreased no change decreased 
Nrp2 no change no change decreased decreased 
Sema3a no change no change no change no change 
Sema3c increased no change no change no change 
Unc5c no change no change no change no change 
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Discussion 
 Early life exposure to the stimulant cocaine alters the expression profile of genes 
involved in axon guidance and neuronal circuit formation.  We examined the expression 
levels of 7 genes from three different AGM families in two brain regions after two 
different periods of cocaine exposure and report that cocaine-induced regulation of 
AGM-related genes is not restricted to a particular family, brain region, or time period.  
Rather, it appears that regulation of AGMs may occur through a generalized mechanism 
and it is likely that other AGMs are regulated by cocaine as well.  Cocaine may induce 
widespread synaptic changes by regulating the abundance various families of AGMs 
simultaneously. 
PN cocaine exposure increased expression of the netrin-1 receptor Dcc in the PFC 
after cocaine exposure during PN week 2 but expression of the Unc5c receptor was 
unchanged.  Opposite results were seen in adult animals exposed to amphetamine where 
only Unc5 levels were increased in the PFC (Yetnikoff et al., 2007).  The observed 
differences could be due to the fact that Dcc levels in the PFC are highest in the 
embryonic brain and decrease with age but Unc5 expression is highest in the adult brain.  
Dcc may be crucial for the formation of synapses and target selection, whereas Unc5 may 
play more of a role in the maintenance of synapses.  
While a previous study reported elevated Ephb1 after prenatal and PN cocaine 
exposure in the STR (Halladay et al., 2000), we found no changes in Ephb1 expression in 
either brain region at the two timepoints measured.  This could be due to the differences 
in dosing paradigms and mRNA detection method used in the two studies.  Halladay and 
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colleagues administered 30mg/ml cocaine twice per day from PN3-16, a significantly 
longer time period of exposure.   
The semaphorin molecule Sema3c is a guiding repellant for mesencephalic DA 
neurons that express its receptors Nrp1 and Nrp2 (Hernandez-Montiel et al., 2008).  
Cocaine-induced changes in these molecules may modify mesolimbic DA connections in 
the PFC/STR and nigrostriatal terminals in the STR.  Regulation of Nrp1 may also 
disrupt inter-hemispheric circuits as this receptor has been shown to mediate callosal 
connectivity in upper layer cortical neurons (Piper et al., 2009).  
The rodent brain experiences a growth trajectory that is not directly comparable to 
humans.  It is estimated that PN10-14 in the rodent brain corresponds to the third 
trimester in humans and PN17-21 in the rodent brain corresponds to early childhood in 
humans (Clancy et al., 2007).  Based on our findings in rodents, prenatal exposure to 
cocaine during the third trimester of human gestation may disrupt the natural trajectory of 
axon outgrowth by regulating the abundance of AGMs.  In addition, exposure to 
therapeutic stimulants for the treatment of conditions such as Attention Deficit 
Hyperactivity Disorder may also regulate AGM expression in young children.    
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CHAPTER V 
 
 
BINGE COCAINE ADMINISTRATION IN ADOLESCENT RATS AFFECTS 
AMYGDALAR GENE EXPRESSION PATTERNS AND ALTERS ANXIETY-
RELATED BEHAVIOR IN ADULTHOOD 
 
 
Abstract 
Administration of cocaine during adolescence alters neurotransmission and behavioral 
sensitization in adulthood, but its effect on the acquisition of fear memories and the 
development of emotion-based neuronal circuits is unknown.  We examined fear learning 
and anxiety-related behaviors in adult male rats that were subjected to binge cocaine 
treatment during adolescence. We furthermore conducted gene expression analyses of the 
amygdala 22 hours after the last cocaine injection to identify molecular patterns that 
might lead to altered emotional processing.  Rats injected with cocaine during 
adolescence displayed less anxiety in adulthood than their vehicle-injected counterparts. 
In addition, cocaine-exposed animals were deficient in their ability to develop contextual 
fear responses. Cocaine administration caused transient gene expression changes in the 
Wnt signaling pathway, of axon guidance molecules, and of synaptic proteins, suggesting 
that cocaine perturbs dendritic structures and synapses in the amygdala. Phosphorylation 
of glycogen synthase kinase 3 beta, a kinase in the Wnt signaling pathway, was altered 
immediately following the binge cocaine paradigm and returned to normal levels 22 
hours after the last cocaine injection.  Cocaine exposure during adolescence leads to 
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molecular changes in the amygdala and decreases fear learning and fear responses in 
adulthood. 
  
Introduction 
 Cocaine is a psychostimulant drug that has long lasting behavioral and 
neurobiological consequences (Lidow, 2003, Nestler, 2005, Kauer and Malenka, 2007, 
Marin et al., 2008). While cocaine usage in teenagers has shown a downward trend in the 
last decade, many young Americans still experiment with drugs and/or alcohol during 
their formative adolescent years (NIDA InfoFacts, 2010). All drugs of abuse target 
subcortical dopaminergic reward pathways and it is important to fully understand how 
stimulation of these pathways can affect a developing brain with immature circuitry 
(Koob and Volkow, 2010).  
 Chronic drug use impairs cortical inhibition of impulsive actions and subcortical 
dopamine release in reward pathways, and promotes risk-taking and drug-seeking 
behaviors (Jentsch and Taylor, 1999). Administration of cocaine during adolescence and 
subsequent activation of dopaminergic pathways may restructure brain anatomy, 
physiology and function, and lead to various behavioral deficits in adulthood. We 
administered cocaine in a binge administration paradigm during adolescence (Black et 
al., 2006) and studied the behavioral response of cocaine-exposed rats to anxiety-evoking 
situations and fear learning.  
 The amygdalar nuclei form a circuit with the prefrontal cortex (PFC) and 
hippocampus that is responsible for detecting contextual and spatial information during 
fear conditioning, and for discriminating dangerous from innocuous stimuli (Fuchs et al., 
82 
2009). We demonstrated previously that binge-cocaine exposure during adolescence 
alters normal PFC function in adult rats (Black et al., 2006). The PFC processes 
information from external stimuli that encode cues for drug-seeking behaviors, anxiety 
and fear learning (Davidson, 2002). Prelimbic FC afferent connections to the amygdala 
are required for the consolidation and expression of learned fear behaviors, whereas 
infralimbic FC-amygdala connections modulate extinction behaviors (Corcoran and 
Quirk, 2007). Corticoafferent projections of the basolateral amygdala to the PFC modify 
glutamatergic tone after chronic cocaine exposure (Orozco-Cabal et al., 2008). Efferents 
from the hippocampus to the amygdala are critical for the extinction of fear (Corcoran et 
al., 2005).  
 Recent evidence suggests that drugs of abuse modulate axon guidance molecules 
in adult rodents and cause synaptic remodeling that may reinforce the cycle of addiction 
(Halladay et al., 2000, Bahi and Dreyer, 2005, Yetnikoff et al., 2007). Here we provide 
evidence that cocaine exposure during adolescence results in gene expression changes in 
axon guidance and Wnt signaling pathways in the amygdala, and disrupts performance in 
amygdala- mediated fear learning and anxiety tasks. 
 
Material and Methods 
Animals  
 All animals were housed and maintained in accordance with the policies of the 
Vanderbilt Animal Care and Use Committee. Male Sprague-Dawley rats (n=111; Charles 
River, Wilmington, MA) weighing approximately 50g (postnatal day (P) 28 – P28) on 
arrival were housed in pairs in clear plastic cages. Food and water was available ad 
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libitum except where noted. The colony room was maintained on a 12h:12h light-dark 
cycle (lights on at 6:00 am). Animals were handled daily for at least a week before 
initiation of experiments. All behavioral testing took place during the light cycle and in 
independent groups of rats. 
 
Drug Administration Protocol  
 Cocaine hydrochloride (Sigma; St. Louis, MO) was dissolved in 0.9 % saline and 
administered intraperitoneally (i.p) at 5, 10, and 15 mg/kg, in a volume of 1µl/g body 
weight. 0.9% saline was used for all vehicle injections. Three injections were given per 
day, 1 hour apart, in accordance with the binge cocaine protocol previously developed by 
our group (Black et al., 2006). Escalating doses of cocaine were administered within a 
12-day period from P35 to P46, equivalent to the period from early adolescence to young 
adulthood in humans. From P35 to P36 rats received 5 mg/kg t.i.d. cocaine or vehicle. 
From P37 to P39, rats received 10 mg/kg t.i.d. cocaine or vehicle, and from P42-46, rats 
received 15 mg/kg t.i.d. cocaine or vehicle (figure 5.1). 
 
 
 
FIGURE 5.1: Overview of experimental time courses.  
Ascending doses of cocaine were administered to adolescent rats from P35 to P46. Rats 
received I.P. injections three times per day (t.i.d.), 1 hour apart, of 5 mg/kg (P35-P36), 
10mg/kg (P37-P39), or 15 mg/kg (P42-P46) cocaine or saline vehicle. Subsets of rats 
were sacrificed at various timepoints after the last injection for molecular studies, or 
tested as adults in behavioral tasks that evaluated amygdalar and hippocampal functions.  
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Elevated Plus Maze  
 All animals were habituated to the testing room for one hour. Adult male rats 
(P70) were placed on the elevated plus maze (Hamilton Kinder, Poway, CA) for 5 
minutes and their movement was tracked using a ceiling-mounted video recording device 
and ANY-maze software (Stoelting, Wood Dale, IL). The maze was made of black 
plexiglass with 4-arms, 85 inches above the ground. The two closed arms had 40cm high 
walls while the open arms were without enclosing walls. All tests were carried out in red 
light. An animal was considered to be occupying a zone if 100% of its body was in that 
zone. Statistical significance was determined using the student’s t-test. 
 
Contextual Fear Conditioning  
 Video freeze software and operant chamber equipment (Med Associates, St. 
Albans, VT) were provided by the Vanderbilt Rat Neurobehavioral Core. On training 
day, adult male rats (P75) were habituated to the testing room for one hour prior to 
testing. Rats were placed in an operant chamber with natural scented oil as an odorant cue 
(The Body Shop; Littlehampton, UK) for a total of 7 minutes. After a two-minute 
acclimation period, animals were exposed to a 30 second, 5 kHz, 70 dB tone, the 
conditioned stimulus (CS), which coterminated with a 1 second, 0.5 mA foot-shock, the 
unconditioned stimulus (US). The tone and shock pairings were repeated three times and 
rats were removed 45 seconds after the last shock. 24 hours later, the animals were placed 
in the same chamber with scent, but without shock or auditory stimuli for 4 minutes. The 
animals’ fear response was recorded as the percentage of time the animal spent freezing. 
A freezing episode was defined as the absence of movement for at least three seconds. 
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Repeated measures ANOVA for 1-minute bins, and post-hoc Tukey-Kramer HSD tests 
were used to determine statistical significance with JMP software (Cary, NC).  
 
Open field  
 Animals were placed for 60 minutes in automated locomotor activity chambers 
(Med Associates, St.Albans, VT) measuring 43.2 X 43.2 X 30.5 cm (length X width X 
height). Movement and activity was monitored by photocell beam breaks and analyzed 
with the Activity Monitor Software (Med Associates). The perimeter along the walls of 
the chamber was designated as the “exterior” zone, while the space in the center of the 
arena 7.5 cm from the wall was designated as the “interior” zone. Resting time refers to 
episodes in which the animal did not ambulate for at least 2 seconds. Statistical analysis 
was carried out with repeated measures ANOVA for 5-minute bins.   
 
Hole Board Food Search and Exploration Tasks 
 Experiments were carried out in sound-attenuated activity chambers (Med 
Associates) with pictures of easily identifiable geometrical shapes on each side (figure 
5.3E,F). The chambers were fitted with floor inserts containing sixteen holes 1.25" in 
diameter placed on 3" centers (four rows of four equidistant holes) with an underlying 
food tray. The task was automated using infrared beams and software that logs hole 
entries. To increase the valence of food, rats were food restricted to 90% of their daily 
food intake measured over the previous five days, with their weights closely matched and 
monitored (figure 5.3A). Food restriction was initiated on P64 and maintained throughout 
the experiment. On P65, rats were placed in the chambers for 15 minutes with holes 
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unbaited. Exploratory behavior was calculated by measuring the number of holes the 
animal entered (novel entries), the number of times the animal returned to the same hole 
(repeat entries), and the total number of entries into any hole during the first 5 minutes. 
On P66, P69 and P70 rats spent 15 minutes in the chambers and four holes were baited 
with sucrose pellets. Acquisition began on P71, with the same four holes baited. 
Acquisition consisted of blocks of 10 one-minute sessions per day. Rats were removed 
after one minute or when all four baited holes had been visited and all food was retrieved, 
whichever came first. Acquisition trials were carried out on P71, P72, P73, P76, P77, P78 
and P79. A reversal trial was carried out on P80. For the reversal trial, four new holes 
were baited (figure 5.3F). The pertinent calculations of the software were working 
memory ratio (novel entries into baited holes / all entries into baited holes) and reference 
memory ratio (all entries into baited holes/total entries into all holes). Statistical 
significance was determined using a student’s t-test. 
 
Morris Water Maze 
 A circular Morris water maze tank (175 cm diameter X 63.5 cm high) was filled 
35.5 cm high with water (22°C) and made opaque using powdered milk. The perimeter of 
the tank was divided into 4 equally sized quadrants, each containing a drop spot, 
distinguished by the letters N, S, E, or W written above the water line. Distinct high-
contrast visual cues were placed on the walls above each quadrant. A 10 cm square clear 
Plexiglas platform placed 2.5 cm below the water surface and at least 36 cm from the 
wall of the tank was used for escape. Ten rats were tested starting at 24 days post-cocaine 
treatment (P70). No drug was administered during this task.  
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Training. On days 1-3, rats completed 2 training sessions per day, each composed of 4 
trials in the morning (~10:00 am) and 4 trials in the afternoon (~3:00 pm). The inter-trial 
interval was approximately 15 minutes. The escape platform was in the same quadrant for 
all training sessions (e.g. in N). For each trial, rats were removed from their homecage, 
placed into the water facing the tank wall, and allowed to swim freely for a maximum of 
60 sec. Once a rat located the escape platform (e.g. located in the N quadrant), it was 
removed from the water and latency to escape was recorded. If a rat failed to locate the 
platform in the allotted time, it was guided to the platform and left there for 10 sec, 
before being removed and returned to its homecage. In this case, latency was recorded as 
90 sec. Drop spots were pseudo-randomized so that each rat started a trial at each drop 
spot only once per session, and drop spots were matched between cocaine and vehicle 
treatment groups.  
Reversal 1. On day 4 in the afternoon session, the platform was moved to a new quadrant 
(e.g. S) and latency to escape was recorded for 60 sec. The reversal consisted of 6 trials. 
The morning session on day 5 consisted of 4 trials with the platform located in the new 
quadrant (e.g. S).  
Reversal 2. The second reversal was carried out during the afternoon session on day 5. 
The platform was moved to a new quadrant not previously used (e.g. E). 
 
Microarrays  
 Rats were sacrificed 22 hours after the last cocaine injection on P47 by rapid 
decapitation. Brains were quickly removed and stored at –80ºC until dissection on a 
freezing microtome. Amygdala was dissected in 2 mm round tissue punches at – 1.7 mm 
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bregma and – 2.5 mm bregma (Paxinos and Watson, 1986), yielding two slices for the 
left and right side of brain. Each punch was 0.8 mm thick. The punches contained the 
central amygdaloid nucleus, basolateral amygdaloid nucleus, and basomedial amygdaloid 
nucleus with all their subdivisions. RNA was extracted with the RNagents kit (Promega, 
Madison, WI) according to company protocol. Double-stranded cDNA was synthesized 
with the help of an oligo-dT-T7 RNA polymerase primer and a cDNA synthesis kit 
(Invitrogen, Carlsbad, CA). Biotinylation was carried out with the Gene Chip Expression 
3’ Amplification kit for IVT (Affymetrix,). Hybridization to the array and washing and 
staining were performed according to company protocol. Samples from individual 
subjects were hybridized to individual arrays. Only samples that reached commonly 
accepted quality control criteria defined by Affymetrix, dChip (Li and Wong, 2001) and 
RMAExpress (Bolstad et al., 2003) were used in the analysis. 
Programs used for data collection included GeneChip Operating Software 
(GCOS, Expression Console; Affymetrix) for scanning and to obtain quality control data, 
and RMAExpress (Bolstad et al., 2003) for quantile normalization and background 
correction to compute expression values for all probe sets. The Database for Annotation, 
Visualization and Integrated Discovery (DAVID, v6.7) (Dennis et al., 2003, Huang da et 
al., 2009),  was used to group regulated genes into functional annotations provided by a 
number of databases.  
 
QPCR  
 Microarray findings were verified with quantitative PCR (QPCR) in technical as 
well as biological replicates. RNA was extracted using the PureLink Micro to Midi RNA 
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extraction kit (Invitrogen). cDNA was synthesized from 0.3-1 µg of total RNA with the 
iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA). A primer set for each gene was 
designed with the help of Primerblast (http://www.ncbi.nlm.nih.gov/tools/primer-blast) 
for amplicons between 150 and 250 base pairs. Melt curve analysis and polyacrylamide 
gel electrophoresis were used to confirm the specificity of each primer pair. QPCR 
reactions were carried out using a Stratagene ThermoCycler and iQ SYBR Green 
Supermix (Bio-Rad) or Brilliant II SYBR Green Supermix (Agilent Technologies, Santa 
Clara, CA). PCR cycling conditions were as follows: an initial step of 95°C for 10 min, 
followed by 40 cycles of 94°C for 15s, 55°C for 15s, 78°C for 15s. Data were collected at 
78°C. Dilution curves were generated for each primer in every experiment and on every 
plate by diluting cDNA from a control sample 1:4 three times, yielding a dilution series 
of 1.00, 0.25, and 0.0625, and .015. All samples were examined in duplicate. Values were 
normalized to the internal controls ß-actin, alpha tubulin, 18s RNA, and general 
transcription factor IIB, which were not regulated by the drug paradigm. The list of 
primer pairs is shown in table 5.1. 
 
Western Blotting  
 Groups of animals were sacrificed on P46 20 minutes after the first injection and 
20 minutes after the final (third) injection, and on P47 22 hours after the final injection. 
Brains were removed and dissected as described above. Tissue was sonicated in Laemmli 
buffer, heated to 80°C for 10 minutes and proteins were electrophoresed on 10-20% 
gradient Tris-Glycine gels (Invitrogen). Proteins were transferred to PVDF membranes 
and blocked with animal-free blocking solution (Vector Laboratories, Burlingame, CA). 
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Primary antibodies were diluted in blocking solution and incubated with membranes 
overnight at 4°C. The following antibodies were used: anti-actin (Sigma, St.Louis, MO), 
anti-phospho GSK3 beta (Serine 9), and anti-total GSK3 beta, (Cell Signaling, Danvers, 
MA). Membranes were washed in TBS-T and incubated for an hour at room temperature 
with HRP-conjugated secondary antibodies (Vector Laboratories) prepared in blocking 
solution. Blots were immersed in chemiluminescent reagents (Pierce, Rockford, IL) and 
exposed and analyzed on the KODAK Imaging Station IS440. Statistical significance was 
determined using a student’s t-test.  
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TABLE 5.1: Primer sequences for QPCR reactions 
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Results 
Adolescent cocaine exposure decreases anxiety and conditioned fear behaviors in 
adult rats 
 
In the elevated plus maze, cocaine-exposed rats spent significantly more time in 
the open arm than vehicle–treated rats (figure 5.2A). Rats that received cocaine during 
adolescence had fewer entries into the closed arms and less distance traveled inside the 
closed arms than the vehicle-treated group (figure 5.2B,C). No difference was observed 
in the center and open arms in either distance traveled or number of entries.  
 To examine learned fear we used the conditioned freezing paradigm. The 
amygdala, the brain area most closely associated with fear and anxiety, evolved with the 
olfactory system, and in the rat receives dense projections from the olfactory bulb to alert 
the animal to scents associated with danger (Davis, 1992, Moreno and Gonzalez, 2007). 
Therefore, we used scented oils in the operant chambers during fear conditioning and on 
the testing day. While no difference in freezing was observed on the day of training, the 
cocaine-exposed group froze less on the testing day than the vehicle group (figure 5.2D). 
A time by group interaction was found (F(3,14)=4.89; p= 0.016), and post-hoc analysis 
confirmed significant decreases in freezing behavior at minute 1 (vehicle=29.4 ± 8.4%; 
cocaine=11.3 ± 5.6%) and minute 2 (vehicle=62.9 ± 8.2%; cocaine=19.0 ± 7.5%) (figure 
5.2E). Thus, cocaine exposed animals did not develop the same contextual fear response 
as the vehicle - exposed rats. 
Movement and behavior of rats in the open field area were monitored for a total 
of 60 minutes. The cocaine-exposed rats spent a greater proportion of time in the interior 
zone than vehicle - exposed rats (main effect of treatment, F(1,11)=8.8, p=0.01; figure 
5.2F). This was not just restricted to a quick crossing of the interior, but was also observ- 
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FIGURE 5.2: Adolescent binge cocaine exposure disrupts fear learning and anxiety behaviors in 
adult rats. A,B,C: Behavior in the elevated plus maze. A: Total time spent in center, closed, and open 
arms shows cocaine-exposed rats spent more time in the open arms than vehicle treated animals. B: 
Total number of entries into each zone of the maze showed cocaine-exposed rats entered the closed 
arms less frequently. C: Distance traveled in each zone showed cocaine-exposed animals traveled less 
in the closed arms. D,E: Results of the conditioned freezing paradigm. D: Percent freezing before and 
during training, and on testing day. ‘Pre-tone’ measures the first 190 seconds the animal was placed in 
the chamber prior to shock or tone. ‘Training’ refers to the pre- and post-tone, as well as the 
conditioning phase where animals received the conditioned (tone) and unconditioned (shock) stimuli. 
‘Testing’ is the average measure of freezing over 4 minutes, 24 hours after conditioning. E: Freezing 
time during the testing period of the contextual fear conditioning paradigm. Post-hoc analysis revealed 
significant decreases in freezing behavior at 1 and 2 minutes. F,G: Behavior in the open field. Zone 
time was recorded for 60 minutes and separated into 5-minute bins. White circle, vehicle; black circle, 
cocaine. Shown is the ratio of time spent in the interior part of the chamber over time spent in the 
exterior part of the chamber (I/E) for all observed movements (F), and time spent resting, in which the 
animal did not ambulate for at least 2 seconds (G). All data average ± SEM; Elevated Plus Maze 
vehicle n= 8; cocaine n= 9; contextual fear conditioning vehicle n= 10; cocaine n= 9; open field 
vehicle n=6; cocaine n=8. 
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ed in the resting time measures (F(1,11)=10.9, p=0.01; figure 5.2G). Overall distance 
traveled was not different between the groups (cocaine: 5901 ± 521; vehicle 6724 ± 659; 
cm average ± SEM). 
 
Adolescent cocaine exposure increases novelty seeking and exploratory behaviors in 
adult rats 
 
 In the hole board exploration task, exploration and anxiety were measured by the 
number of novel entries, repeat entries, and total entries with the snout into a hole during 
a 5-minute novel exposure to the 16-hole chamber. Cocaine-exposed rats entered the 
chamber’s holes at a higher frequency than the saline-exposed rats, although holes were 
not baited (figure 5.3B). Distance traveled and time spent ambulating or resting in the 
interior part of the chamber that included the holes, and the residual perimeter next to the 
walls of the chamber, were comparable for both groups (figure 5.3C, D). However, 
cocaine-exposed rats had a higher ratio of time spent resting in the interior part of the 
chamber/residual part of the chamber (figure 5.3D).  
 
Adolescent cocaine exposure does not impair spatial learning and memory in adult 
rats 
 
 The hole board food search task and the Morris water maze task were used to 
assess spatial learning and memory function. The hole board food search task measures 
working memory and reference memory. The working memory ratios and reference 
memory ratios were between 30-50% on the first day of acquisition (figure 5.3G,H), after 
three days of habituation. Both groups of rats improved in their performance over time 
and no significant differences were seen in any aspect of the task, indicating that the 
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FIGURE 5.3: Exploration and novelty seeking is increased in adult rodents after 
binge cocaine administration in adolescence.   A: Weight curves and treatment 
schedules for animals undergoing the hole board tasks. B-D: Hole board exploration. E-
H: Hole board food search task. B: Novel, repeat, and total entries into unbaited holes 
during a 5-minute novel exposure to the hole board chamber. C: Distance traveled in the 
interior and exterior part of the chamber during novel exposure. D: Resting (not 
ambulating for at least 2 seconds) and ambulatory time spent in the interior part of the 
chamber or the exterior part of the chamber during novel exposure. I/E is the ratio of 
interior time over exterior time. E, F: Hole board food search design with baited holes in 
black. High-contrast shapes were placed on the four walls of the chamber as reference 
points. Areas of internal and external measurements are shown. E: Holes baited during 
habituation and acquisition; F: Holes baited during the reversal trial. G: Working memory 
ratio (novel entries into baited holes / all entries into baited holes) in the hole board food 
search task. F: Reference memory ratio (all entries into baited holes/total entries into all 
holes) in the hole board food search task. All data average ± SEM; vehicle n=8; cocaine 
n=8. 
96 
cocaine-exposed rats learned the task as well as the vehicle-treated rats. Although upon 
novel exposure to the operant chamber (hole board exploration) differences in hole 
entries were observed between the groups, no differences were seen on the subsequent 
three days of habituation when holes were baited with sucrose pellets. Working and 
reference memory trials were therefore not influenced by different levels of anxiety to 
enter the holes. In a reversal test on the 8th day, no significant differences were observed 
between the groups. The reversal showed that rats had learned to not re-visit the baited 
holes, as their working memory ratio was similar to the last acquisition day (figure 5.3G). 
The decrease in reference memory ratio upon reversal shows that the rats first visited the 
previously baited, now unbaited holes, before checking the other holes (figure 5.3H). The 
decrease in reference memory ratio verified that the rats were using their memory to find 
the sucrose pellets. 
The Morris water maze task was carried out in morning and afternoon sessions on 
five consecutive days (figure 5.4). On the afternoon sessions of days 4 and 5, different 
reversals of the platform location were introduced. No difference in performance was 
observed between the groups. 
 
Binge cocaine exposure regulates amygdalar gene expression in adolescent rats 
To determine if a molecular pattern was associated with impaired fear learning 
and anxiety, we conducted gene expression microarray assays on the amygdala from a 
subset of rats killed 22 hours after the last injection. Genes that were changed by less than 
10% were excluded as well as those that were considered below detection level in 40% or 
more of all samples. Significance was determined with a student’s t-test and only genes 
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FIGURE 5.4: Spatial learning and memory were not altered in adult rats after adolescent 
cocaine exposure.  The Morris water maze task was carried out in morning and afternoon sessions on 
five consecutive days, with 4 trials per session. In the afternoon sessions of days 4 and 5, different 
reversals of the platform location were introduced. No difference in performance was observed 
between the groups. A: Morris Water Maze data with all trials per session averaged. Quadrant with 
platform location is shown above the bar graphs. Time to reach platform is averaged for all trials per 
session per day. B: Individual trials for reversal sessions 1 and 2. C: Difference in time to reach the 
platform between day 4 am and day 4 pm (first reversal; F(1,8)=0.37, p=0.560), and between day 5 am 
and day 5 pm (second reversal; F (1,8)=0.6, p=0.463). White circle, vehicle; black circle, cocaine. 
Abbreviations: Rev, reversal; N = north, S = south, E = east; data average ± SEM, vehicle n=5; 
cocaine n=5. 
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that had a p value of less than 0.05 were considered for further analysis. We used the 
DAVID database to examine annotation clusters that identify common pathways in a list 
of regulated genes (Dennis et al., 2003, Huang da et al., 2009). Because of redundancy in 
annotation records, we used annotation clustering to identify enriched gene groups in 
multiple categorical classifications.  
 A group of downregulated genes was identified with an enrichment score of 3.37, 
which contained genes in pathways termed “synapse”, “synapse part”, “plasma 
membrane”, and “cell junction”. Members of this group are shown in table 5.2. No 
particular pathway was identified in the group of upregulated genes. However, in the 
entire group of regulated genes several pathways were significantly affected by cocaine 
exposure. These pathways were related to development of synapse structure and growth 
and included “axon guidance” (table 5.3) and “Wnt signaling” (table 5.4). Quantitative 
PCR (QPCR) on a subset of genes confirmed the gene array data (figure 5.5). The list of 
primer sequences is provided in table 5.1. A technical replicate was performed for several 
genes in each pathway (figure 5.5A). 
 
Wnt signaling is dysregulated following adolescent cocaine exposure  
Additional analysis in another cohort was performed to verify regulation of the 
Wnt signaling pathway (figure 5.5B). The altered expression of Wnt5a and Wnt7a could 
not be verified in the QPCR analysis and only showed trends for regulation (data not 
shown). However, Wnt11, a gene that had a low present call in the microarray analysis, 
was found to be significantly elevated in cocaine exposed animals (figure 5.5B). The 
microarray analyses revealed an increase in glycogen synthase kinase 3 beta  (GSK3B) 
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TABLE 5.2: Adolescent cocaine exposure leads to downregulation of plasma 
membrane and synaptic genes in the amygdala.  Microarray analysis revealed a group 
of 37 genes classified as “synaptic” or “plasma membrane part” that were downregulated 
in animals that received cocaine during adolescence. Shown are the probe set IDs, gene 
name, accession number, fold changes, and p-value (based on log2-transformed data). 
Vehicle n=6; cocaine n=7. 
 
 
 
 
 
 
TABLE 5.3: Adolescent cocaine exposure alters the expression of axon guidance 
genes in the amygdala.  Regulated axon pathway genes are listed with their respective 
probe set IDs, gene name, and accession number. Vehicle n=6; cocaine n=7. 
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TABLE 5.4: Adolescent cocaine exposure alters the expression of Wnt signaling 
pathway genes in the amygdala.  Regulated Wnt signaling pathway genes are listed 
with their respective probe set IDs, gene name, and accession number.  Vehicle n=6; 
cocaine n=7. 
 
 
 
mRNA levels in the amygdala 22 hours after the last injection (table 5.4). To determine if 
cocaine regulates GSK3B activity, we measured total GSK3B protein as well as levels of 
GSK3B phosphorylated at serine residue 9, in the amygdala of rats that were sacrificed 
20 minutes after the first or third injection on the last day of the dosing paradigm, or 22 
hours after the last injection. Phosphorylation of GSK3B at serine residue 9 was 
increased after the first injection but decreased after the third injection. No changes were 
seen in the total amount of GSK3B protein (Figure 5.6). No changes in phosphorylated or 
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FIGURE 5.5: Adolescent cocaine exposure affects the expression of synaptic and developmental 
genes in the amygdala. Quantitative PCR verification of gene expression changes observed in the 
microarray analyses. A: Technical replicate performed on the original cohort of animals from 
microarray studies confirms the microarray results. B: Biological replicate performed on an additional 
cohort of animals confirms regulation of genes of the Wnt signaling pathway. Slit2 (p<=0.01; not 
shown) and Tgfb3 were also examined to verify findings in the original cohort Values were 
normalized to the control genes beta actin, alpha tubulin, 18s RNA, and GtfIIB. For a complete list of 
gene names, please refer to tables 5.2-5.4. Statistical significance was determined with a student’s t-
test, * p<=0.05. Average + SEM; technical replicate vehicle n=6; cocaine n=6; biological replicate 
vehicle n=10; cocaine n=8.were sacrificed 20 minutes after the first or third injection on the last day of 
the dosing paradigm, or 22 hours after the last injection. Phosphorylation of GSK3B at serine residue 
9 was increased after the first injection but decreased after the third injection. No changes were seen in 
the total amount of GSK3B protein (figure 5.6). No changes in phosphorylated or total GSK3B were 
seen 22 hours after the last injection, indicating that GSK3B phosphorylation had returned to normal 
levels.  
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FIGURE 5.6: Cocaine administration during adolescence regulates GSK3B 
phosphorylation patterns in the amygdala.  Representative western blots of total 
GSK3B protein and phosphorylated GSK3B in amygdala tissue punches from animals 
sacrificed 20 minutes after the first injection on the last day of the paradigm (left bar 
graphs), 20 minutes after the last injection (center bar graphs), or 22 hours after the last 
injection (right bar graphs). Phosphorylated GSK3B protein was normalized to total 
GSK3B protein. Percent change in intensity relative to vehicle samples is graphed. 
Average + SEM; for blots of rats sacrificed 20 minutes after the first or last injection, 
vehicle n=7; cocaine n=7; for blots of rats sacrificed 22 hours after the injection 
paradigm, vehicle n=6; cocaine n=6.  * p<=0.05. 
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total GSK3B were seen 22 hours after the last injection, indicating that GSK3B 
phosphorylation had returned to normal levels. 
 
Discussion: 
Exposure to drugs of abuse during adolescence could affect the developmental 
trajectory of the brain with lasting consequences for structure, function and behavior. 
Here we provide evidence that adolescent cocaine abuse has deleterious behavioral 
effects in adulthood, well after cessation of drug use. During cocaine exposure, protein 
phosphorylation and gene expression patterns were altered, as measured on the last day of 
cocaine treatment. This interference with normal molecular processes led to altered 
behavior in adulthood. A previous study in the PFC showed that the changes in gene 
expression patterns are mostly transient, while the behavioral consequences are long-
lasting (Black et al., 2006). Since we used the same experimental paradigm, it is 
reasonable to assume that the molecular patterns in the amygdala normalize as well, an 
assumption supported by the fact that in the present study GSK3B phosphorylation was 
normalized 22 hours after the last cocaine injection. However, transient changes in gene 
and protein expression can interfere with the normal program of brain development and 
have permanent consequences beyond that age period. 
Cocaine exposure during adolescence decreased guarded behaviors and fear 
learning in adult rats. Although fear learning was abnormal, learning and memory 
paradigms not related to fear were normal. Rats exposed to cocaine during adolescence 
were more likely to enter into the open arm of an elevated plus maze, or the less protected 
areas of the open field, and to inspect the holes in the hole board without hesitation. 
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These behavioral changes indicated that cocaine exposure in adolescence reduces 
cautious behavior in adulthood.  
 Increased impulsivity and risk-taking in human cocaine users are well known 
(Marzuk et al., 1992, Bornovalova et al., 2005), though it is not known if this is a pre-
existing trait leading to drug use, or a consequence of drug use. Here we used a rat model 
with no pre-existing traits and show that drug exposure during adolescence decreases 
cautious behavior in adulthood. Thus, drug use during adolescence can lead to long-term 
adverse behaviors. Although it is presently not known if similar adaptations can occur 
during adult cocaine use, it should not detract from the importance of the long-lasting 
effects of adolescent cocaine use. Onset of drug use during adolescence is a significant 
predictor of the subsequent development of addiction (Grant and Dawson, 1998), and as 
we show here, as well as in our previous study (Black et al., 2006), alters behavior in 
adulthood. 
 The behavioral changes observed indicate that cocaine affects amygdalar 
physiology. Therefore we conducted gene expression analyses to identify groups of genes 
or pathways in the amygdala that are altered immediately after cocaine exposure. Groups 
of genes involved in synaptic function, axon guidance and Wnt signaling, were 
significantly changed in the amygdala of cocaine-exposed rats. Changes of axon guidance 
molecules by psychostimulants have also been reported in other brain areas but this study 
is the first to report cocaine-induced alterations in axon guidance molecules in the 
amygdala (Halladay et al., 2000, Bahi and Dreyer, 2005, Jassen et al., 2006, Xiao et al., 
2006, Grant et al., 2007, Yetnikoff et al., 2007). These systems are dynamically regulated 
by cocaine and a given gene or protein may be initially increased and subsequently 
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repressed, or vice versa. Thus, although the direction of regulation might be dependent on 
the timing of tissue harvest after the final cocaine injection, the fact that cocaine affects 
these transcripts is a crucial observation. 
Axon guidance and Wnt signaling are important developmental processes that 
modulate the correct target selection of synapses and dendritic structures, as well as the 
patterning of neurotransmission and overall neuronal circuit formation (Chen and Cheng, 
2009, Bashaw and Klein, 2010). In the adult striatum, GSK3B regulates the heightened 
locomotor activity and sensitivity after cocaine administration (Miller et al., 2009). 
Decreased phosphorylation of GSK3B at serine residue 9 in the amygdala was seen 
previously in the adult rodent after cocaine exposure (Perrine et al., 2008). After the first 
injection on the last day of our paradigm, GSK3B was hyperphosphorylated but after the 
third injection phosphorylation was decreased, presumably through the activation of a 
feed-back mechanism. The molecular data indicate that cocaine dysregulates the 
signaling pathways associated with GSK3B in the amygdala. GSK3B regulates the 
activity of beta catenin, a transcription factor that promotes the expression of many target 
genes, including receptors, cell adhesion molecules, cell cycle regulators, growth factors, 
and cytoskeletal proteins (figure 5.7). The downregulation of synaptic proteins, together 
with the alterations in axon guidance and Wnt pathway genes, points to a reorganization 
of synapses and dendritic structures in the amygdala by cocaine, which might be the 
reason for the long-term behavioral changes we observed. 
 Psychostimulants like amphetamine and cocaine prevent the clearance of 
dopamine and other biogenic amines from the synapse and potentiate their signaling 
(Kahlig et al., 2005). Dopamine as well as serotonin modulate developmental processes 
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such as proliferation, cell migration, and differentiation (Jones et al., 2000, Ohtani et al., 
2003, Popolo et al., 2004, Bonnin et al., 2007, Crandall et al., 2007). From the present 
study we conclude that during adolescence aberrant monoamine signaling can affect 
developmental processes that pattern connectivity in the amygdala, with lasting effects on 
fear, anxiety, and emotion. The transient exposure to cocaine during adolescence could 
result in “mis-wiring” of emotional circuitry and fear recognition systems, leading to 
detrimental behaviors later in life.  
 Decreased anxiety could be perceived as a favorable characteristic, but 
recognition of danger and judicious behavior is imperative for the survival of a species 
(Griskevicius et al., 2009). Since healthy levels of anxiety mediate cautious behavior in 
novel or dangerous situations, we conclude that the decreased caution after adolescent 
cocaine exposure could lead to increased “risk-taking” in adulthood. 
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FIGURE 5.7: Schematic representation of cocaine-induced amygdalar gene changes in 
the Wnt pathway.  Adolescent cocaine exposure regulated the mRNA expression of many 
genes involved in Wnt signaling pathways. These signaling pathways can alter the 
morphology of the actin cytoskeleton and participate in the remodeling of synaptic and 
dendritic structures following exposure to drugs of abuse. Signaling by Wnt molecules leads 
to the activation of transcription factors and target genes. In the canonical Wnt pathway, 
dishevelled inhibits a kinase-associated scaffolding complex (GSK3B, casein kinase, PP2A) 
that normally facilitates the degradation of beta catenin. Free beta catenin translocates to the 
nucleus where it activates the transcription of Wnt target genes. Dishevelled, as well as axon 
guidance molecules, also induce changes in actin polymerization and cytoskeletal proteins 
via the activation of Rho GTPases. The calcium-mediated Wnt signaling pathway is 
controlled by the Wnt5 molecules and activates transcription of cell surface proteins and cell 
adhesion molecules. Shown in green are upregulated genes and shown in red are 
downregulated genes. Solid arrows show direct interactions and dashed arrows denote 
signaling processes with intermediates not shown. Abbreviations: CaLN, calmodulin; LEF, 
lymphoid enhanced binding factor; PLC, phospholipase C; TAK1, Tgf beta activated kinase 
1; TCF, t-cell transcription factor; TGFBR1/2, transforming growth factor beta receptor 1/2. 
For a detailed list of all other genes names see table 5.4.  
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CHAPTER VI 
 
SUMMARY AND FUTURE DIRECTIONS 
 
 The purpose of this study was to evaluate the molecular and behavioral 
consequences of DA system stimulation during brain development.  The combination of 
in vitro studies of embryonic neurons with early PN drug exposure provides insight into 
DA-mediated effects over a range of developmental time-periods. 
 
DRD1 and DRD2 have unique expression patterns in the developing brain  
 Expression of the two main DRs, DRD1 and DRD2, was measured in the 
developing rat brain from E15 to E21.  During this period of embryogenesis, which 
roughly corresponds to the second trimester of human fetal development (Clancy et al., 
2007), the initial patterns of connectivity and DA innervation are established in the mFC 
and STR, laying a foundation for the neural circuitry that plays an integral role in the 
modulation of neurotransmission.  Two different methodologies were used to measure 
mRNA levels of the receptors and similar patterns of DR expression were observed with 
each.  In situ hybridization was used to provide a broad overview of the major areas 
containing DRs, but was combined with QPCR for more accurate and sensitive 
quantification of DR levels.   
 DR expression in the cortex was not confined to the mFC and was observed 
throughout the cortex, including the orbital, lateral, and motor cortices as well as the 
septum.  However, DRD2, and to a lesser extent DRD1, appeared to be more 
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concentrated in the deeper cortical layers at later developmental timepoints (Figures 2.2-
2.3), which is in agreement with a previous study that reported that layer 5 contains the 
highest levels of DRs (Lidow et al., 1998).  Deep cortical layers are largely composed of 
principal neurons and relay information to subcortical brain areas (Caviness et al., 2008).           
 At the earliest time-point measured, E15, low levels of DRs were detected in both 
brain regions (Figure 2.4).  The trajectories of both DRs changed significantly over time 
in the two brain regions but at different rates.  Significant differences were seen in the 
trajectories of the two receptors when compared to one another, indicating that the 
induction of DR-subtypes is not uniform.  Very steep increases in DR mRNA were 
observed at E17 in the STR and at E19 in the mFC, which is in concordance with the 
arrival of DA fibers in those brain regions.  While levels of both DRs were significantly 
higher in the STR compared to the mFC, the ratio of DRD1:DRD2 differed between the 
mFC and the STR:  DRD1 levels were higher than DRD2 in the mFC but DRD2 was 
higher than DRD1 in the STR (Tables 2.2 and 2.3).  The STR most likely contains more 
DRs because it receives DA innervation from both the VTA and the SN.  This study did 
not compare levels of DRs in multiple regions of the STR as it is likely prone to error due 
to the size of rat brains at early embryonic time-points.   
 To determine the expression patterns of DRs in vitro, mRNA levels of DRD1 and 
DRD2 were measured in primary neuronal cultures after 1-6 DIV, isolated from rat brains 
at E15 (Figure 2.5).  The trajectory of DR expression was similar to that seen in tissue 
samples, with large inductions of receptor mRNA overtime, and levels of DRD1 higher 
than DRD2 in the mFC.  In the STR, DRD2 was higher than DRD1 at only one time-
point but overall the trajectories of the two receptors were different.  This lack of DRD2 
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mRNA induction was not observed in cultured neurons obtained from E18 embryos.  
Because neurogenesis is ongoing from E15 to E21, the neuronal population obtained at 
E15 will not be the same as that obtained from later time-points.  Cells born after E15 
may contribute to the induction of DRD2 mRNA by providing environmental cues, 
transcription factors, and more DRD2 positive neurons.  Therefore, the levels of DRs in 
primary neuronal cultures were not directly comparable to the levels of DRs in tissue 
samples.  However, DA innervation at later time-points may also promote induction of 
receptor mRNAs. 
  
DR signaling cascades are functional in the absence of DR innervation 
 Since DA could be a contributing factor in the organization of neuronal networks 
in DR-expressing neurons of the developing brain, the functionality of DRs was assessed 
in primary neuronal cultures, obtained from E15 or E18 embryos.  These time-points 
were chosen to compare the signaling properties of DRs before and after DA fibers have 
reached the mFC and STR (Figure 1.1).  Little DA innervation occurs in the STR at E15, 
while the mFC receives no innervation.  At E18, dopaminergic fibers are present 
throughout the STR but remain in the intermediate zone of the cortex, waiting to enter the 
cortical plate until E20 (Van den Heuvel and Pasterkamp, 2008).       
  At E15 both DRs were functionally coupled to phosphorylation cascades, 
indicating that DR-mediated signaling can occur in the developing brain prior to DA 
innervation (Figure 2.6 and 2.7).  In the mFC, DRD1 stimulation increased ERK1/2 
phosphorylation at both time-points but CREB phosphorylation was only increased at 
E18.  Likewise, DRD2 stimulation decreased CREB only at E18 in the mFC but 
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decreased ERK1/2 at both time-points in the STR.  In the STR DRD1 stimulation 
increased CREB and ERK1/2 phosphorylation at E15 and E18, as well as GSK3β 
phosphorylation at E15.  DRD2 stimulation decreased GSK3β at both time-points in the 
mFC and STR.  The robustness of phosphorylation responses seen in the STR may be due 
to the fact that DA fibers innervate the STR before the mFC, suggesting that exposure to 
DA aids in the functional maturation of DRs.  Region-specific disparities in DRD2-
mediated CREB and ERK1/2 phosphorylation may contribute to specific developmental 
events that occur in the two functionally distinct brain regions.  Pretreatment of E18 mFC 
cells with the DRD1 antagonist SCH23390 did not disrupt DRD2-mediatiated activation 
of GSK3β (Figure 2.8), indicating that the DR agonists used in this study do not cross-
react with multiple DR-subtypes. 
 Because DA positive fibers do not invade the cortical plate until E20, DRs in the 
fetal brain may be activated by other monoamines such as serotonin, which is released by 
the placenta (Bonnin 2010), or another ligand that is expressed developmentally.  
Alternatively, other sources may deliver DA into the mFC during embryogenesis.  At 
early stages of gestation the blood brain barrier has not been completely sealed, exposing 
the embryo to the maternal blood supply for nutrition.  Platelets and lymphocytes express 
both the dopamine transporter DAT and the vesicular monoamine transporter (VMAT) 
and can uptake and release DA (Amenta et al., 2001, Zucker et al., 2001, Frankhauser et 
al., 2006).  The placenta is a source of serotonin for the embryonic brain and may contain 
other monoamines, like DA (Bonnin et al., 2011).  Additionally, cells in the mFC may 
transiently express monoamines for a short period of development and release them 
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locally to modulate developmental processes such as axon guidance (Bonnin and Levitt, 
2011). 
 Drugs were applied exogenously in cell culture treatment and high amounts are 
needed to achieve concentrations that will actually reach DRs in the synapse. Although in 
vivo baseline levels of DA are in the nanomolar range (Goto et al., 2007), burst spike-
firing increases DA levels from hundreds of µM to mM levels (Grace and Bunney, 1984, 
Garris et al., 1994, Goto et al., 2007). It has also been demonstrated that the majority of 
DRD1-like receptors in the striatum require µM DA levels for activation (Richfield et al., 
1989, Rice and Cragg, 2008).  
 Finally, the activation of DRs at E15 when mRNA levels are extremely low 
indicates that DRs may be supersensitive in the developing brain. Given the low 
expression levels of DRs, the concentration of DR agonists Activation of DRs at these 
early time-points may influence developmental processes via molecules such as CREB, 
ERK1/2, and GSK3β, all of which may signal to the nucleus to transcribe genes 
important for growth and development.  
 
Ntn-1 receptors are expressed in the developing mFC  
 The Ntn-1 receptors DCC and UNC5C were expressed in the developing mFC 
and co-localized with DRs (Figures 3.1 and 3.2).  While expression of UNC5C followed 
a trajectory similar to that of DRs and appeared to be concentrated in deep cortical layers, 
the pattern of DCC expression differed greatly (Figure 3.1D and 3.1E).  DCC levels were 
high at E15, peaked at E18, then decreased with age (Figure 3.1).  DCC was expressed in 
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a medial to lateral gradient, presumably to guide crossing fibers as the corpus callosum 
forms (Figure 3.1A and 3.1B).  
 DA projections from the VTA synapse onto the pioneer neurons in the mFC that 
send the first axons across from one hemisphere to the other (Carr and Sesack, 2000).  In 
addition, many intracellular signaling molecules affected by DR activity have the 
capability to modulate axon guidance events, including PKA, calcium in growth cones, 
and cyclic nucleotides (Ming et al., 1997, Ming et al., 1999, Halladay et al., 2000, 
Nishiyama et al., 2003, Bouchard et al., 2004, Bonnin et al., 2007).  Since DRs are 
functionally active at this time, release of DA and activation of DR-mediated signaling 
pathways may contribute to the normal development of inter-cortical connectivity.     
  
DR stimulation disrupts Ntn-1 mediated attraction of mFC axons 
 Two types of in vitro assays were used to assess the guidance properties of Ntn-1 
in the presence of DR activation.  First, explant assays were used to measure directional 
outgrowth of mFC neurites in response to Ntn-1 expressing HEK293T cell aggregates 
(Figure 3.3).  Under basal conditions, Ntn-1 attracted mFC tissue explants by promoting 
neurite outgrowth in regions of the explant proximal to the Ntn-1 gradient (Figure 3.3B, 
3.4B, and 3.4E).  Treatment with the DRD1 agonist SKF82958 or the DRD2 agonist 
quinpirole disrupted this effect, causing explants to have more symmetrical outgrowth, 
resembling the effects seen with non-Ntn-1 cells (Figure 3.3 and 3.4).  However, results 
from this experiment indicated that the presence of Ntn-1 or the addition of DR agonists 
did not alter the total outgrowth of mFC explants (Figure 3.4F), indicating that Ntn-1 
functions as a guidance cue for the directional steering of axons. 
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 This finding was supported by data obtained through the use of microfluidic 
nanochambers, which allow dissociated neuronal cultures to be grown in a channel 
connected to a channel containing recombinant Ntn-1 protein (Figure 3.5).  The two 
channels are separated by microwells that are permissible for individual axon growth.  
The length of axons in the microwells was not affected by the treatment of DR agonists 
but was significantly increased when mFC cells were cultured next to a gradient of Ntn-1 
(Figure 3.5E).   As with explant assays, this effect was disrupted when cultures were 
treated with DR agonists in the presence of Ntn-1.  Co-treatment with Ntn-1 and the 
DRD1 agonist SKF82958 or the DRD2 agonist PPHT resulted in an ~30% reduction in 
axon length compared to cultures treated with Ntn-1 alone (Figure 3.5E).  In both types 
of outgrowth assays, treatment with DR agonists resulted in outgrowth properties similar 
to that seen in untreated controls, suggesting that DR stimulation decreases an axon’s 
responsiveness to Ntn-1 cues and inhibits directional steering of growth cones.  
 
DR stimulation regulates the abundance of Ntn-1 receptor transcripts 
 To identify a molecular basis for the observed outgrowth responses, levels of the 
Ntn-1 receptors DCC and UNC5C were measured with QPCR in E15 mFC cultures after 
treatment with DR agonists (Figure 3.6).  Both DRD1 and DRD2 agonists increased 
expression of UNC5C, the receptor that mediates repulsive guidance responses. 
SKF82958 and quinpirole induced moderate increases in UNC5C expression, while more 
robust responses were seen after treatment with the potent DRD2 agonist PPHT.   Co-
stimulation of both receptor subtypes with the partial DRD1/DRD2 agonist apomorphine 
resulted in the most dramatic changes in UNC5C expression, with ~50-75% increases 
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that were maintained after 4 hours.  No changes in DCC expression were observed after 
DR stimulation. 
 By regulating the abundance of UNC5C transcripts, DR stimulation could change 
the ratio of DCC:UNC5C in mFC neurons.  Since homodimers of DCC promote 
attraction, increased expression of UNC5C may result in more DCC:UNC5C 
heterodimers and promote repulsion or decreased attraction to Ntn-1 cues.  This effect 
could be important for axon fibers crossing the midline, as they will need to be attracted 
to the midline initially but repelled away from the midline once they have crossed.  The 
dynamic ratio of DCC to UNC5C during mFC development implies a functional switch 
in growth cone responses to Ntn-1 cues that may be augmented by DR-induced increases 
in UNC5C expression.  Additionally, Ntn-1 is expressed in high levels in the 
subventricular zone of the STR and the ratio of Ntn-1 receptor expression could be 
important for corticofugal mFC axons as they project subcortically (Serafini et al., 1996, 
Metin et al., 1997, Donahoo and Richards, 2009). 
 Further investigation is needed to fully understand the effects of DR signaling on 
Ntn-1 mediated guidance in the mFC.  While the specificity of DR agonists was 
demonstrated in figure 2.8 by co-application of the DR agonist PPHT with the DRD1 
antagonist SCH23390, it is possible that DR agonists may interact with other non-DA 
receptors to regulate axon guidance.  It will be important to further decipher the 
components of DR signaling that directly affect the Ntn-1 system to establish a link 
between the two pathways.  This study could be strengthened through the use of 
additional pharmacological agents that target DRs and their second messenger pathways.       
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 However, DR antagonists do not simply block DRs but instead induce signaling 
cascades of their own which could confound data interpretation (Konradi and Heckers, 
1995, Jassen et al., 2006, Sutton et al., 2007).  Manipulation of DR expression in vivo 
through the use of in utero electroporation would provide information about the trajectory 
of mFC axon outgrowth when DR levels are altered.  Transfection of DR siRNA into 
tissues in vivo or neuronal cultures in vitro could be combined with DR agonist treatment 
to show that lack of DRs prevents inhibition of ntn-1-mediated attraction.  Importantly, 
the trajectory of mFC projections could be tracked in whole embryonic brains after 
removal of DRs to determine if DR stimulation is required for the normal development of 
mFC projections.   
 Likewise, knockdown of UNC5C receptor mRNA in combination with DR 
agonist treatment would establish a relationship between DA signaling and ntn-1-
mediated repulsive events.  It is not clear if increased UNC5C levels translate to more 
UNC5C receptor in the growth cone membrane.  Cell-surface biotinylation of ntn-1 
receptors would determine if alterations in translocation rate result from DR stimulation. 
 Because both DRD1 and DRD2 produced similar effects on axon guidance and 
ntn-1 receptor expression, it is necessary to determine how the seemingly different 
pathways of both receptors cause the same response.  Both DRs mobilize calcium 
intracellularly and affect transcription of genes involved in growth and development.  
Axon guidance is very sensitive to calcium transients but too much or too little calcium 
can switch an axon cue from attraction to repulsion.  Measuring calcium levels in the 
growth cone after DR stimulation may provide information about DR-subtype-specific 
calcium transients associated with guidance.  For example, DRD2 may decrease calcium 
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transients while DRD1 increases them.  Under these conditions, both receptors could 
cause suboptimal calcium homeostasis and prevent attraction to ntn-1 cues.  If calcium 
homeostasis is the underlying cause of DR-mediated inhibition of ntn-1 attraction, then it 
is very likely that DRs accomplish this by activating the Gαs (DRD1), Gαi (DRD2), or Gαq 
(DRD2) pathways.  Each of these g-proteins can affect intracellular calcium levels.  
Selective stimulation of DRs in combination with inhibitors of their respective signaling 
molecules, such as PKA, GSK3β, and PLC, is necessary to elucidate DR signaling 
pathways involved in ntn-1 mediated guidance.  Further insight into the mechanism of 
DR action could be obtained by identifying UNC5C transcription factors that are 
regulated by DR agonists. 
 The early expression and functionality of DRs and their capability to activate 
signaling cascades provides the DA system with a powerful position to influence the 
progression of brain development and neural network connectivity. Based on the data 
shown here, any source of prenatal DA, including maternally supplied DA, and 
abnormalities in fetal DR function could thus lead to a miswiring of the brain with 
detrimental consequences for brain function later in life. 
 DR-mediated disruption of axon guidance may not be specific for the Ntn-1 
pathway, as increased prenatal dopaminergic signaling has been shown to regulate 
expression of ephrin family genes in the STR (Halladay et al., 2000).  Other families of 
axon guidance genes may be regulated by DR stimulation as well, but further research 
employing functional outgrowth assays in dopaminoceptive regions will be needed to 
address these questions.  
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Postnatal cocaine administration regulates expression of axon guidance-related genes 
in the mFC and STR 
 
 Many axon guidance molecules (AGMs) are present in the adolescent and adult 
brain, well after synapse formation has occurred.  AGMs may have additional roles in 
developed brains such as maintaining synaptic connections and dendritic architecture.  
The psychostimulant drugs cocaine and amphetamine regulate expression of AGMs in 
adult animals.  Lack of the Ntn-1 receptor DCC disrupts sensitization, suggesting that it 
contributes to the symptoms and neuropathology of addiction (Bahi and Dreyer, 2005, 
Yetnikoff et al., 2007, Yetnikoff et al., 2010, Sillivan et al., 2011).  Because these drugs 
increase dopaminergic tone, they can be used to examine the effects of DR stimulation on 
axon guidance pathways in vivo.  The molecular and behavioral consequences of PN 
cocaine exposure were examined at three different developmental time periods in the rat. 
 mRNA levels of 7 axon-guidance related genes were measured after cocaine 
administration during weeks 2 and 3 of PN rat development (Figure 4.1).  Cocaine 
regulated expression of 3 different families of AGMs in the PFC and STR, indicating that 
stimulant-induced gene expression changes are not limited to one axon guidance family 
but instead may be a generalized effect (Figure 4.2 and Table 4.2-4.3).   Because the time 
periods examined here correspond to the third trimester of human fetal development, 
these data indicate that cocaine usage during pregnancy may regulate expression of 
AGMs in utero (Clancy et al., 2007).   
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Adolescent binge cocaine administration regulates expression of developmental and 
synaptic genes 
 In an adolescent binge cocaine paradigm, cocaine was administered in ascending 
doses to male rats from PN35-46.  Immediately after the last injection, a subset of 
animals were sacrificed and examined in gene expression and protein phosphorylation 
studies. A previous study using the same paradigm described gene changes in the PFC 
after adolescent cocaine exposure but few were related to developmental processes 
(Black et al., 2006).  Cocaine exposure altered performance in an attentional task that is 
mediated by the PFC, suggesting that other aspects of PFC function may be impaired as 
well.  Since the PFC participates in amygdala-based responses to anxiety and learned fear 
(Davidson, 2002, Corcoran and Quirk, 2007, Sotres-Bayon and Quirk, 2010), molecular 
and behavioral components of amygdalar activity were assessed after adolescent cocaine 
exposure. 
 Gene expression studies were conducted in amygdala tissue using microarray 
technology.  Adolescent cocaine exposure regulated the expression of groups of genes 
important for growth and development in the amygdala, including axon guidance events, 
Wnt signaling, and synaptic connectivity (Tables 5.2-5.4).  These changes were 
confirmed with QPCR in biological and technical replicates (Figure 5.4).  Cocaine 
administration produced irregular phosphorylation patterns of GSK3β, a kinase that 
regulates Wnt pathway signaling, that normalized after 21 days (Figure 5.5).  Additional 
research is needed to determine if these changes occur after adult cocaine administration 
as well, or if they are specific for adolescent cocaine exposure, and whether cocaine 
exposure causes neuroanatomical alterations in amygdalar synaptic structure.  Transient 
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changes in genes responsible for establishing connectivity, such as AGMs, may cause 
abnormal circuit formation, resulting in long term behavioral changes.         
 
Adolescent binge cocaine administration decreases fear and anxiety in adult rats  
  To address this question, another subset of animals were maintained into 
adulthood with no additional cocaine exposure and subjected to tests that measure 
behaviors regulated by the PFC and amygdala (Figure 5.1).  Cocaine-exposed animals 
spent more time in the center area of an open field arena and more time in the open arm 
of an elevated plus maze as compared to vehicle treated animals, indicating a decrease in 
levels of innate anxiety (Figure 3.2).  During the hole board exploration task, cocaine 
exposed animals were more exploratory and novelty seeking, exploring more holes at a 
higher frequency than vehicle treated animals (Figure 3.3). 
 In a contextual fear conditioning paradigm, no differences in freezing behavior 
were observed upon presentation of a shock paired with a conditioned stimulus.  
However, 24 hours later, vehicle treated animals froze significantly more than cocaine 
exposed animals when presented with the same context but no stimulus, suggesting that 
cocaine exposure impairs the development of normal learned fear responses and the 
retrieval of fear memories (Figure 3.2).  Cocaine exposure did not cause a generalized 
learning deficit because both groups of animals developed equal fear responses on day 1 
of the paradigm.  Likewise, spatial learning and memory behaviors were intact as the two 
groups performed equally well in the Morris Water Maze and the hole board search food 
task (Figure 3.3).   
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 The immediate gene changes in the amygdala after cocaine exposure may 
establish circuitry that promotes risk-taking behaviors and decreased anxiety later in life.  
While this may be considered advantageous to some, it is necessary for the survival of a 
species to be able to discern an innocuous stimuli from a harmful one, and to exercise 
caution when danger is present.   
 Research presented here demonstrates that DA system stimulation in the 
developing brain disrupts axon guidance events and may alter neuronal circuit formation 
in multiple brain areas by regulating the expression of genes and proteins involved in 
growth and development.  Since the amygdala, FC, and STR are important for cognition, 
attention, movement, emotion, and learning, aberrant connectivity of these regions could 
impair behavior later in life, as seems to be the case in schizophrenia (Zalesky et al., 
2011). 
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